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The International Laboratory for Research on Animal Diseases (ILRAD) was established in
1973 with a mandate to develop effective control measures for livestock diseases which
seriously limit world food production. ILRAD's research program focuses on African animal
trypanosomiasis and East Coast fever, a form of theileriosis.
ILRAD is one of 13 centres in a worldwide agricultural research network sponsored by the
Consultative Group on International Agricultural Research (CGIAR). In 1987, funding for
ILRAD's essential research and training activities was provided by the World Bank
(International Bank for Reconstruction and Development—IBRD), the United Nations
Development Program (UNDP), the African Development Bank (ADB), the Rockefeller
Foundation and the Governments of Belgium, Canada, Denmark, France, Germany (Federal
Republic), India, Italy, Japan, the Netherlands, Norway, Sweden, Switzerland, the United
Kingdom (UK) and the United States of America (USA). Additional research activities were
supported by special funding arrangements from the European Economic Community (EEC)
and the World Health Organization (WHO) and capital funds were provided by the
Government of The Netherlands for construction of a new training and ourteach building.
All responsibility for views and information expressed in this report remains with ILRAD. The
use of trade names does not imply endorsement of any product.
The correct citation for this report is: ILRAD (International Laboratory for Research on Animal
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Foreword
The International Laboratory for Research on Animal Diseases (ILRAD) was established in
1973 with a mandate to conduct intensive research leading to improved control of livestock
diseases. ILRAD now occupies a modern complex of research laboratories and support
facilities at Kabete on the outskirts of Nairobi, Kenya, and has a cattle breeding ranch at
Kapiti, about 50 km from Nairobi. In 1987, ILRAD's full complement of staff included 59 senior
scientific and administrative personnel, 24 specialised technicians, 51 technical support staff
and 287 in general support categories. Research and training activities concentrate on
immunological and related aspects of two diseases which seriously limit food production in
Africa and other developing regions of the world—African animal trypanosomiasis and East
Coast fever (ECF), a virulent form of theileriosis.
Despite intensive research efforts at ILRAD and in other laboratories, the current situation
regarding control of ECF and trypanosomiasis is not yet satisfactory. Control of ECF is still
based primarily on control of the tick vector by regular acaricide treatment plus pasture
management and exclusion of wildlife. Control of trypanosomiasis is largely based on
insecticidal control of the tsetse vectors and the use of trypanocidal drugs, both to prevent
infection and to treat infected animals. New techniques have been developed to control some
tsetse species, but overall the area of Africa infested by tsetse has increased rather than
diminished. At the same time, no new trypanocidal drug has been introduced for general use
for nearly 30 years and the potential development of drug resistance remains a serious threat.
Thus ILRAD continues to work towards developing a practical means of immunization against
ECF and improving control measures for trypanosomiasis.
As ILRAD has matured, the need has grown for stronger research management to maintain
program focus and efficiency in the use of resources. In line with recommendations made in
ILRAD's External Program and Management Reviews and accepted by the Board of Directors,
research program management has been strengthened by the appointment of Coordinators for
the Theileriosis and Trypanosomiasis Research Programs. The Director of Research and the
two Program Coordinators now comprise a Research Review Committee which considers
program needs, planning, assessment and direction together with the Program Committee of
the Board of Directors.
ILRAD's Theileriosis Research Program continues to be organized in three project areas.
These deal with aspects of epidemiology and the development of vaccines based on antigenic
molecules derived from either Theileria sporozoites or schizonts. The Trypanosomiasis
Research Program has been partly restructured to give increasing emphasis to research
activities which will lead to benefits in the shorter term. Thus, research on trypanosomiasis
epidemiology now includes work on the development of diagnostic tests, improved
chemotherapy, the prevention or management of drug resistance and the use of
trypanotolerant livestock. ILRAD's other trypanosomiasis research activities, with a longer-term
perspective, will continue to include basic research on the biochemistry of trypanosomes and
on host responses to infection. The goal is to identify points in the cycle of infection which
might be susceptible to chemical or immunological intervention. A new project area has also
been added to the program concerned with the pathogenesis of infection, particularly the
development of anaemia and reproductive disorders. Developments in 1987 included the
construction of a new laboratory, changes in the use of three existing laboratories and some
regrouping and relocation of scientific staff to relieve congestion and to meet new program
needs. ILRAD is now well placed to move into a further phase of productive research on both
theileriosis and trypanosomiasis.
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The results of ILRAD's research and training activities in 1987 comprise the bulk of this report
and need not be detailed here. However some notable achievements from the research
programs may be mentioned. In the theileriosis program, field trials to test the efficacy of
immunization by infection with Theileria sporozoites plus antibiotic treatment have been
completed successfully in Kenya and are now in progress in Tanzania and Zimbabwe. A well-
characterized strain of Theileria parva has been made available to the Kenya Agricultural
Research Institute for field evaluation in infection and treatment immunization in Kenya's
Coast Province. Parasite stocks are being characterized using monoclonal antibodies and
recombinant DNA (deoxyribonucleic acid) technology and substantial progress has been made
in the development of techniques for preparing genetically homogeneous Theileria
populations.
In the search for T parva antigens which might be used as the basis of a vaccine, several
candidate molecules have been identified in the sporozoite form of the parasite and a protein
associated with the schizont stage of parasite development has been recognized by
monoclonal antibodies. Scientists are now characterizing the genes which encode these
molecules. Techniques which allow the transfer of genes from one cell to another have been
introduced at ILRAD, primarily to facilitate research on immune mechanisms in theileriosis.
Studies on the bovine immune system are a basic requirement for research on both
theileriosis and trypanosomiasis and have wider relevance for studies on other diseases.
Monoclonal antibodies were prepared in 1987 which recognize subsets of bovine B
lymphocytes and macrophages to supplement reagents identified in previous years which
characterize subsets of bovine T lymphocytes. The bovine major histocompatability complex
(MHC) plays a fundamental role in the generation of immune responses. The emphasis in
ILRAD's research on the MHC has moved from definition of class I molecules to class II
molecules during the year. Current work on the MHC in ruminants, rodents and man was
reviewed at an international workshop held at ILRAD in September. This meeting of
specialists from many laboratories has led to new collaborative research projects on the
bovine MHC.
Research on the biology and biochemistry of trypanosomes emphasizes mechanisms of
antigenic variation and development through different life cycle stages which are essential for
parasite survival. Particular attention has been given to the ingestion, metabolism and
transport of protein molecules and to the cell organelles involved in these processes which
could provide targets for immune or chemical attack.
Research continues on the nature of trypanotolerance in cattle. Experiments at ILRAD have
clearly demonstrated the superior ability of N'Dama cattle to control parasite numbers in the
bloodstream and to resist anaemia during repeated trypanosome infections. The role of
immunological memory in this superior resistance is now being investigated. Additional
N'Dama calves are being produced at ILRAD by embryo transfer. In 1987, 31 embryos
recovered from 5 N'Dama heifers were implanted in Boran foster mothers, resulting in 22
pregnancies and 11 births.
Scientists are developing better methods for diagnosing trypanosome infection using
monoclonal antibodies and DNA probes. Attention focuses on simplifying the technology for
more widespread use in the field, particularly to identify species such as Trypanosoma
congolense and T simiae which are difficult to distinguish by conventional techniques. To
support improvement in trypanosomiasis control by drug treatment, scientists are using
trypanosome culture techniques developed earlier to assess the drug sensitivity of different
trypanosome stocks. New methods are also being developed to measure the levels of
trypanocidal drugs present in treated animals.
The trypanosomiasis epidemiology program includes participation in the African
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Trypanotolerant Livestock Network covering sites in 9 countries. ILRAD is collaborating with
the International Livestock Centre for Africa (ILCA) and national livestock ministries to
determine how to maximize the productivity of N'Dama and other trypanotolerant livestock
under a variety of conditions. One Network project involves typing N'Dama cattle from Zaire
and The Gambia according to class I MHC antigens in order to identify genetic markers which
may predict inherent resistance to trypanosome infection. An international conference was
held at ILRAD in 1987 to review research findings and consider the future direction of Network
activities.
During 1987, a new Epidemiology and Socio-economics Unit was established at ILRAD. Its
goal is to assess the impact of trypanosomiasis and ECF in selected areas of Africa and to
evaluate the potential economic, social and environmental effects of improved disease control.
Initial emphasis will be on evaluating the impact of infection and treatment immunization
against ECF.
A total of 13 scientists, veterinarians and senior technicians came to ILRAD in 1987 for
training attachments or to broaden their research experience. All were staff members of
univerisities or national veterinary research laboratories and most came from African
countries. In addition, four courses were held during the year, attracting a total of 44
participants. Fifteen university graduates from African countries worked at ILRAD in 1987 as
Research Fellows on projects leading to an M.Sc. or Ph.D. degree and two Senior Research
Fellows came to ILRAD from universities in East Africa to undertake 1-year research projects.
During 1987, ILRAD prepared proposals for research and training programs for the 5-year
period from 1988 to 1992. These medium-term proposals took into account consideration of
ILRAD's short-term and long-term research strategies and the recommendations of the
External Program and Management Reviews. They were approved by the Technical Advisory
Committee of the Consultative Group on International Agricultural Research (CGIAR) and
recommended to the donors for funding. The CGIAR's acceptance of research planning on a
5-year basis is a welcome development, since it eases the burden of detailed annual program
and budget reviews by the Technical Advisory Committee and recognizes the long-term nature
of many aspects of basic research. In June 1987, ILRAD hosted the mid-year meeting of the
Technical Advisory Committee and the Directors of the other 12 international agricultural
research centres supported by the CGIAR.
ILRAD scientists participate actively in a number of collaborative research and training
projects with national and international organizations in African countries affected by
trypanosomiasis and ECF. Collaborative activities in 1987 included participation in the biennial
meeting of the Organization of African Unity's International Scientific Council for
Trypanosomiasis Research and Control (OAU/ ISCTRC) held in Togo and in a review of the
Food and Agriculture Organization of the United Nations' (FAO) Program for the Control of
Tick-borne Diseases, covering activities in Zimbabwe, Malawi, Tanzania, Burundi, Uganda and
Ethiopia.
In concluding this foreword, I would like to express appreciation to the Board of Directors, the
scientific and supporting staff and the donor organizations and nations who collectively
support ILRAD's research and training activities. Three members of the Board of Directors
retired in 1987. These were Dr K. Warren, Dr C. L'Ecuyer and Dr G. Kazyumba. Three new
members joined the Board—Dr P. Englund of the Johns Hopkins University School of
Medicine (United States of America—USA), Professor I. Maansson of the Swedish University
of Agricultural Sciences and Dr A.S. Sidibe of the OAU's InterAfrican Bureau for Animal
Resources (IBAR) in Mali. Professor Hans Jahnke was elected Chairman of the Board of
Directors.
We acknowledge with gratitude the interest and financial support ILRAD receives from many
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countries and organizations. In 1987, ILRAD continued to receive core funding from the World
Bank (International Bank for Reconstruction and Development—IBRD), the United Nations
Development Program (UNDP), the African Development Bank (ADB), the Rockefeller
Foundation and the governments of Belgium, Canada, Denmark, France, Germany (FR), Italy,
Japan, the Netherlands, Norway, Sweden, Switzerland, the United Kingdom (UK) and the
USA. The Government of India added its support during the year. Additional research activities
were supported by the European Economic Community (EEC) and the World Health
Organization (WHO).
In 1987, ILRAD was honoured to receive visits from a number of important guests. These
included Ms W. Demeester, the Belgian Secretary of State for Public Health, the Honourable
P. Nvue, Minister of Agriculture for the Equatoria Region of Sudan, Dr E. Schuh, Director of
Agriculture of the World Bank, Professor J. Di Bioggio, President of Michigan State University
(USA), Professor W. Lavery, President of Virginia College of Science and Technology (USA),
Dr D. Acker and Dr W. Furtick, Directors of Agriculture of the United States Agency for
International Development (USAID), Dr R. Manning, Deputy Director General of the Australian
Development Assistance Bureau, Mr A. Bennett, Chief Natural Resources Adviser to the
Overseas Development Administration (UK), and Dr W. Dietel, Chairman of Winrock
International (USA).
Several important visitors from the Government of Kenya came to ILRAD during the year.
These included the Honourable W.O. Omamo, Minister for Research, Science and
Technology, the Honourable K. Mwendwa, Minister for Livestock Development, the
Honourable R. Oyondi, Assistant Minister for Livestock Development and Mr J. Adamba and
Mr D. Mbiti, Permanent Secretaries in the Ministry of Livestock Development.
ILRAD received visits from Their Excellencies, the Ambassadors of Denmark, Italy, Japan,
The Netherlands and the USA, and the High Commissioners of Australia, Canada and the UK.
Dr S. Sinding, Director of the USAID Mission in Kenya, also visited ILRAD.
Finally, it is always a pleasure to acknowledge the support ILRAD has received through the
years from the people and Government of Kenya. We look forward to the continuation of this
warm relationship with our Kenyan hosts.
A.R. Gray
Director General
ILRAD
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Theileria is a genus of tick-transmitted protozoan parasites infecting wild and domestic animals
in many parts of the world. In East and Central Africa, the most important species—Theileria
parva—represents a major constraint on the development of beef and dairy production.
Theileria annulata causes disease in cattle over a broad area, extending from the
Mediterranean littoral to the Middle East, India, Southern Russia and Asia, while Theileria
orientalis affects cattle in the Far East. In the Middle East, Theileria hirci causes disease in
sheep and goats.
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Theileria parva causes a virulent form of theileriosis that threatens some 25 million cattle in
Kenya, Tanzania, Uganda, southern Sudan, Rwanda, Burundi, Zaire, Malawi, Zambia,
Zimbabwe and Mozambique. Three forms of the disease occur in the region. For convenience,
these are described by distinguishing three subspecies of the parasite. The term East Coast
fever—ECF—is used to describe the classical disease caused by Theileria parva parva, which
is transmitted between cattle by the brown ear tick, Rhipicephalus appendiculatus. Corridor
disease is caused by T p lawrencei, transmitted by the same tick to cattle from buffalo
(Syncerus caffer). A milder form of theileriosis is caused by T p bovis, also transmitted by the
tick Rhipicephalus appendiculatus.
All these parasites have a complex life cycle in the mammalian host and the arthropod vector.
R appendiculatus is a three-host tick, feeding on separate animals as a larva, a nymph and an
adult. The parasites are transmitted most commonly when ticks feed on infected animals as
nymphs and then on susceptible cattle as adults.
Theileria parasites pass through a sexual stage in the gut of the tick and enter the salivary
glands where they form an elaborate intracellular sporoblast. During tick feeding, the
sporoblast gives rise to 30,000 to 50,000 infective sporozoites. These are injected into cattle in
tick saliva. In cattle, they attach to and enter lymphocytes, white blood cells of the immune
system. Within the lymphocytes, the sporozoites develop into schizonts and the infected
lymphocytes are transformed into enlarged lymphoblasts which multiply together with the
schizonts, resulting in a rapidly expanding population of parasitized cells. The final stage of
disease is characterized by large-scale cell destruction, often leading to death.
During the course of infection, some of the Theileria schizonts differentiate into merozoites
which are released from the lymphocytes into the bloodstream. These invade red blood cells
and develop into piroplasms. Ticks become infected when they ingest red blood cells
containing piroplasms, initiating a new cycle of parasite development.
ECF is controlled principally by dipping or spraying cattle with acaricides to kill the tick vectors.
However, frequent dipping or spraying is expensive, and cattle remain fully susceptible to
disease if there is any interruption of the acaricide regime. Tick resistance to the available
acaricides is also a problem and most acaricides are environmentally damaging. Two curative
drugs have been developed for the treatment of ECF, but they are expensive and theileriosis
must be diagnosed at an early stage for treatment to be most effective. Thus, there is an
urgent need for alternative methods of ECF control.
At the same time, cattle which recover from ECF show long-lasting immunity, suggesting that
there are good prospects for controlling the disease by immunization. However, there is
antigenic diversity among theilerial strains and immunity against one strain does not
necessarily protect cattle against another. The total number of strains is unknown, but it may
be limited, and certain isolates or combinations of isolates appear to provide a broad
protection. ILRAD places particular emphasis on improving existing methods of immunization
by infection and treatment and on developing new approaches to immunization against ECF.
 Epidemiology and experimental immunization
Experimental procedures for immunization against ECF were initiated in southern Africa and
further developed at the former East African Veterinary Research Organization in Kenya.
These are based on infection with T parva sporozoites and simultaneous treatment with
tetracycline antibiotics. This method offers the most practical and effective form of
immunization currently available and it is being tested in extended field trials in several
countries. The disadvantages are that infection with live parasites must be carefully controlled
and protection may not be achieved in areas where immunologically unrelated strains of the
parasite are present. Also, cattle may become carriers of the parasites used for immunization.
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The most urgent requirement for a better understanding of ECF epidemiology and for
improving and extending control by infection and treatment is a simple and reliable method for
characterizing parasite strains. The primary method available at present is cross-immunity
testing in cattle, but this approach is time consuming and expensive and the results are not
always free of ambiguity. For this reason, scientists at ILRAD are exploring several in vitro
methods of parasite characterization.
Field immunization trials were initiated in 1986 in Tanzania and Zimbabwe, using locally
isolated parasites. In combination with earlier results from Kenya and elsewhere, this work
should provide important information on the effectiveness of infection and treatment
immunization in a variety of epidemiological situations.
 Strain characterization
Cattle which are immune to one population of Theileria may not resist infection with another,
indicating that different, immunologically distinct, groups of parasites exist in the field. If a
vaccine against ECF is to protect cattle against infection, it must stimulate immunity against
the different theilerial parasites which the animals are likely to encounter. Thus, in order to
develop an effective ECF vaccine, there is an urgent requirement for practicable and reliable
laboratory methods to categorize Theileria parasites into antigenic groups and elucidate their
cross-protective potential in cattle. Regional organizations and national governments in
Eastern and Southern Africa also need improved methods of parasite characterization in order
to define the patterns of ECF infection in their countries and to assess current control
programs.
A formal system of parasite characterization is being developed at ILRAD based on a
systematic examination of several different techniques. This work has focused primarily on six
Theileria stocks which have already been relatively well characterized—T p parva Muguga,
Mariakani and Marikebuni from Kenya, T p parva Uganda, T p bovis Boleni from Zimbabwe
and T p lawrencei 7014/Laikipia from Kenya.
Bulk stabilates of each stock have been prepared from ground-up infected ticks and from
dissected tick salivary glands. These have all been tested for infectivity. A standard battery of
bovine cells has been infected with each stock and cell lines established so that all parasites
may be tested against a common host-cell background. Cloned infected cell lines have been
established for many of these stocks by limiting dilution of schizont-infected cells. These
stocks are now being analysed by monoclonal antibody screening, protein analysis and two
methods of DNA characterization.
Work in this area also focuses on developing techniques to obtain homogeneous populations
of Theileria originating from cloned sporozoites. In addition, cells infected with each of the
parasite stocks selected for study are being examined for sensitivity to titrated doses of the
drugs available to treat ECF—oxytetracycline, parvaquone (Clexon: Wellcome), buparvaquone
(Butalex: Wellcome) and halofuginone (Terit: Hoechst). Finally, randomized groups of cattle
will each be immunized with a different one of the six selected bulk stocks and challenged with
the other five. Results will be analysed to determine any relationships or differences between
the stocks. in terms of cross-protection. By the end of 1988, it should be possible to compare
the results of all the studies reported here and to identify any correlations among the different
methods of characterization.
 Screening with monoclonal antibodies
A great deal of work on the characterization of Theileria stocks in vitro has been based on the
recognition of parasite antigens by monoclonal antibodies, detected by the indirect fluorescent
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antibody (IFA) test. Monoclonal antibodies are produced from hybrid cells formed by the fusion
of mouse spleen cells, primed to produce specific antibodies, and mouse tumour cells capable
of growing and multiplying in vitro. Whereas sera from infected cattle can be expected to
respond to a wide range of parasite antigens, monoclonal antibodies are useful for
distinguishing parasite stocks because each one recognizes a single antigenic determinant.
The antigens recognized by monoclonal antibodies are not necessarily responsible for
stimulating immunity in cattle, and thus patterns of monoclonal antibody response may not
correspond with cross-protection patterns in vivo. However, monoclonal antibody responses
are consistent when a parasite stock is used to infect cells from different cattle or after
passage through ticks, indicating that the antigens recognized by monoclonal antibodies are a
fixed character of the parasites.
The monoclonal antibodies raised at ILRAD against Theileria sporozoites appear to detect
surface antigen(s) common to many different parasite stocks, suggesting that a sporozoite
vaccine might confer broad protection. By contrast, some monoclonal antibodies raised
against schizont-infected cells detect antigens specific to different parasite stocks, making
them useful reagents for detecting antigenic differences that might define Theileria strains.
Originally, a panel of 20 anti-schizont monoclonal antibodies was used to screen hundreds of
schizont-infected cell lines isolated throughout the ECF endemic region. As additional
monoclonal antibodies were raised and more isolates were screened, the patterns of
monoclonal antibody response appeared more and more complex. Recent work in this area
has focused primarily on T p lawrencei because parasites isolated from buffalo show
extensive antigenic diversity and, perhaps for this reason, immunity sometimes breaks down
when cattle are exposed to buffalo-derived parasites in the field. These studies have
suggested that buffalo may be infected simultaneously with several antigenically distinct
Theileria populations.
Work in 1987 concentrated on identifying any antigenic characteristics which might be used to
distinguish T p lawrencei, T p parva and T p bovis. Seven new monoclonal antibodies were
raised against T p lawrencei and used to screen five of ILRAD's reference stocks plus
parasites derived from buffalo, but none was specific for T p lawrencei, that is recognizing
antigens on all the buffalo-derived parasites and on none of the others.
 Analysis of parasite proteins
The analysis of Theileria proteins by two-dimensional gel electrophoresis is being investigated
as a means of distinguishing parasite species, subspecies and strains. Another objective is to
identify changes in host-cell proteins which may be associated with Theileria infection.
Parasite schizonts were purified from cloned and uncloned cell lines infected with different
Theileria stocks. These were radiolabeled with 35S-methionine, which labels the majority of
proteins, and the proteins were separated in polyacrylamide gels according to electrical
charge and size. Using this technique, minor differences were observed between ILRAD's bulk
stabilates of T p parva Muguga, Marikebuni and Mariakani (Figure 1). T p bovis Boleni and
the 7014/Laikipia stock of T p lawrencei were indistinguishable from the T p parva stocks, but
another stock of T p lawrencei (IC11/E8) showed marked differences.
Theileriosis
file:///C|/Users/dhmichael/Desktop/fulldoc_html/ilrad87/Theileriosis.htm[5/19/2016 3:35:00 PM]
Figure 1. Theileria schizonts were purified from infected cells which had been radiolabeled
with 35S-methionine. When the purified schizonts were subjected to two-dimensional gel
electrophoresis, more than 200 parasite proteins could be identified. A comparison of two T p
parva stocks—Muguga and Marikebun I—revealed differences in several proteins, as indicated
by the arrowheads.
A comparison of proteins from T parva infected and uninfected bovine cells using different
types of radiolabeling revealed some interesting differences. Using 35S-methionine, a basic
protein of 14,000 daltons was identified which was specific for cells infected with two different
stocks. When another radiolabel was used specifically to identify glycoproteins (protein-
carbohydrate compounds), marked differences were observed between uninfected and
infected cells, with the appearance of some glycoproteins and disappearance of others after
infection. Using a third radiolabel which is specific for cell surface proteins, an acidic protein
was detected which occurred only on the surface of infected cells. Present work in this area
includes biochemical studies of infection-specific proteins plus further analysis of proteins from
different Theileria stocks.
 Observation of DNA sequences
Scientists are looking for differences in DNA sequences which might be used to identify
specific Theileria strains using gel electrophoresis. Theileria DNA is cleaved into fragments
using restriction enzymes and the fragments are applied to one end of an agarose gel. When
electrical charges are passed through the gel, the DNA moves towards the other end.
Because smaller DNA fragments move through the gel more quickly than larger ones, a
pattern emerges, called a genomic profile, with fragments of different sizes at different
positions along the gel.
Digestion of DNA from T p parva Muguga by the restriction enzyme Sfi 1 resulted in
approximately 28 fragments ranging in size from 1 million to 40,000 base pairs. Comparison
among different stabilates of T p parva Muguga showed no differences in genomic profiles,
suggesting that the parasites had remained genetically stable following passage through cattle
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and ticks. When genomic profiles were compared using DNA from different T p parva stocks
and from an isolate of another Theileria species, T mutans, there were detectable differences
in the number and size of fragments in each stock (Figure 2). A second restriction enzyme,
Not 1, cleaved T p parva Uganda, Marikebuni and Kibarani DNA into four fragments and T p
parva Muguga DNA into five. Cleavage with both restriction enzymes revealed clear
differences between T mutans and all the T p parva stocks examined. These differences
remained constant whether DNA was prepared from the sporozoite, schizont or piroplasm
stage of the parasite life cycle. This technique appears promising for the identification of
Theileria stocks and species, but it is not yet clear whether it can be used successfully to
identify potentially cross-protective strains.
Figure 2. DNA from five T p parva stocks and one T mutans isolate was digested with the
restriction enzyme Sfi 1 and analysed using contour-clamped homogeneous electric field gel
electrophoresis. The sizes of different fragments were estimated in 1000 base pairs (kb). No
differences could be observed among three different stabilates of T p parva Muguga (lanes 1-
3), but differences were detected among different T p parva stocks: Muguga, Pemba/Mnarani
(lane 4), Mariakani (lane 5), Uganda (lane 6) and Kibarani (lane 7). There were major
differences between all these stocks and the isolate of T mutans (lane 8).
 DNA hybridization probes
Studies were initiated in 1985 to identify DNA sequences which could be used as probes to
distinguish T parva subspecies and strains. Three clones were produced 1986 containing
segments of T p parva Muguga piroplasm DNA which were present as multiple copies in the
parasite genome. In 1987, additional DNA clones were prepared from T p parva Mariakani
piroplasms. The T p parva Muguga DNA clones were used successfully as probes to
distinguish stocks of T p parva, T p bovis and T p lawrencei in preparations of schizont-
infected cells or purified piroplasms. None of the probes hybridized with DNA from T mutans,
Theileria taurotragi or Theileria annulata, suggesting that they were species specific. Detailed
analysis with these DNA probes has suggested the presence of mixed parasite populations in
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some of the stocks tested.
Experiments were conducted in 1987 to identify any genotypic characteristics which might be
used to distinguish T p lawrencei from T p parva. Two of ILRAD's T p parva Muguga DNA
probes were used to screen DNA prepared from three infected buffalo and from seven cattle
infected with Theileria sporozoites derived from one of the buffalo. The DNA probes revealed
considerable variation in the parasites isolated from the cattle (Figure 3) and none of the cattle
isolates showed the same DNA hybridization patterns as those obtained from the buffalo,
suggesting either that minor parasite populations from the buffalo had been selected and had
established infection in the cattle or that a genetic rearrangement had occurred during
passage of the parasites from buffalo to cattle. None of the buffalo-derived parasites used in
this study showed any specific phenotypic or genotypic characteristics—detectable with
ILRAD's existing monoclonal antibodies or DNA probes—which would distinguish them from T
p parva. These results confirmed evidence from several other studies suggesting that the
classification of Theileria parva parasites into three subspecies, though convenient for workers
in the field, may be without a sound genetic basis.
Figure 3. Seven cattle were infected with sporozoite stabilates prepared from ticks which fed
on a Theileria-infected buffalo. Infected cell lines were isolated from the lymph nodes of the
cattle and parasite DNA from these cells was split into fragments with a restriction enzyme.
This autoradiogram shows the hybridization of one of ILRAD's T p parva Muguga DNA probes
(1gTpM-23) with Theileria DNA derived from the seven cattle. Fragment sizes are indicated in
1000 base pairs (kb). The hybridization patterns reveal considerable genomic diversity.
In 1987, ILRAD scientists also tested whether infections with different Theileria stocks could
be detected in tick salivary glands using the DNA probes developed to detect parasites in
bovine cells. Parasites were detected with two of ILRAD's DNA probes in as few as one
infected acinus from the salivary glands of infected ticks. Infections were detected in more
than 90% of the ticks which had been shown to be infected by light microscopy, indicating that
ILRAD's DNA probes were highly sensitive.
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Future plans include using ILRAD's T p parva DNA probes to examine ticks infected with other
species of Theileria. Work is also in progress using DNA probes to investigate the possibility of
selection or genetic rearrangement during parasite development in the bovine host, the tick
vector or in culture. In addition to their potential use in ECF epidemiological studies, Theileria
DNA probes may eventually provide information on evolutionary relationships between
different T parva stocks.
 Efforts to obtain Theileria clones
There is an urgent requirement for cloned populations of Theileria derived unequivocally from
single parasites. The presence of mixed parasite populations within many of the Theileria
stocks currently available complicates the interpretation of cross-protection experiments. If
cloned parasites can be produced which stimulate protection, these would provide more
standardized material for cross-immunity trials and field immunization programs and would
greatly simplify the analysis of breakthrough infections. Cloned parasites are also required to
explore the possible role of genetic recombination in the antigenic diversity observed in
Theileria parasites.
As mentioned earlier, lymphoid cells from cattle or buffalo are readily infected with Theileria
sporozoites and the resultant infected cell lines subsequently cloned in vitro. However, the
schizonts contained in these cloned cells are not necessarily homogeneous cloned
populations because single host cells may have been infected initially by more than one
sporozoite. To overcome this problem, lymphocytes were infected in vitro with sporozoites
titrated to less than 100 sporozoites per 1 million bovine cells. The resultant infected cell lines
were then cloned twice by limiting dilution and these clones were used to infect the cattle from
which the cells were originally derived. In most instances, infections with these cloned cells
were mild, producing low numbers of Theileria piroplasms. However, parasites were
successfully picked up by feeding ticks and prepared as stabilates and their infectivity is now
being tested. These stabilates will be used for immunological and characterization studies and
to examine for genetic recombination of the parasites in ticks.
 Immunization by infection and treatment
A collaborative project was initiated in 1984 between the Tanzanian Government, the Irish
Government, FAO and ILRAD to test ECF immunization by infection and treatment on
Zanzibar and Pemba islands in Tanzania. Theileria parasites were isolated from both islands
and two stocks—Zanzibar South and Pemba/Mnarani—were characterized which appeared
suitable for use in immunization trials.
The first field trials were conducted on Zanzibar and Pemba in late 1986. These involved
infecting Jersey (Bos taurus) dairy cattle on each island with the locally isolated parasite stock
and treating with oxytetracycline. Cattle on Zanzibar were immunized safely by this procedure
using two doses of the drug and resisted subsequent ECF challenge, but the majority of cattle
immunized on Pemba developed severe ECF reactions following immunization using a single
dose of oxytetracycline. The situation on both islands was complicated by the presence of
several other tickborne diseases.
Two new procedures were tested at ILRAD using Friesian (Bos taurus) cattle and the
Pemba/Mnarani stock. These involved two treatments with oxytetracycline—at the time of
infection and 4 days later—or one treatment with buparvaquone at the time of infection. Both
procedures were effective in controlling the immunizing infection and conferred resistance to
subsequent challenge with the same stock.
Further experiments will test immunization against the Zanzibar South stock using one dose of
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buparvaquone at the time of infection. Both Theileria stocks will also be tested to determine
whether calves below 1 month of age can be immunized successfully. Based on these results,
the Tanzanian Government will be advised on the feasibility of using these stocks for ECF
immunization programs on Zanzibar and Pemba islands.
 Reappearance of parasites following treatment with parvaquone
Treatment of bovine cell lines infected with T p parva Muguga with a high dose (10µg/ml) of
parvaquone resulted in the disappearance of schizonts and death of the cells within a few
days. However, when treated cells were cultured with T-cell growth factor, they continued to
multiply and in over half the cultures Theileria schizonts reappeared several days later.
Schizonts also reappeared when treated cells were cultured with the growth factor human
recombinant interleukin-2 (IL-2) or with supernatant collected from a Theileria-infected bovine
cell line which is known to produce IL-2-like growth factors. Cultures in which schizonts
reappeared eventually became completely parasitized and grew normally in the absence of
growth factors.
Before the reappearance of schizonts in the treated cells, inclusion bodies were observed in
the cell cytoplasm (Figure 4). These became increasingly dense over time, often appearing as
circles or commas within cell vacuoles. The inclusion bodies appeared in all cell cultures,
including those in which schizonts did not reappear. They consisted of DNA and were
recognized by a Theileria-specific DNA probe but not by a schizont-specific monoclonal
antibody. This phenomenon provides a potential explanation for the establishment of carrier
infections in cattle treated with theileriacidal drugs.
Figure 4. Giemsa-stained cytocentrifuge smears showing the development of intracytoplasmic
inclusions and the formation of schizonts in parvaquone-treated, T p parva Muguga-infected
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cells cultured in T-cell growth factor: (A) untreated cells with normal schizont morphology, (B)
small inclusions observed 7 days after treatment, (C) densely staining inclusions 11 days after
treatment and (D) reforming schizonts and schizonts with normal morphology 16 days after
treatment.
 Sporozoite immunization: the search for protective antigens
Cattle which survive in ECF endemic areas appear to develop a degree of immunity to
Theileria infection. Immune responses in these animals include both antibody reponses
against the sporozoite form of the parasite and cytolytic (cell-killing) responses against cells
infected with Theileria schizonts. Antibodies raised against sporozoites of one T parva stock
recognize parasites of other stocks, suggesting that anti-sporozoite antibodies might offer
broad protection against ECF infection.
Sera from cattle exposed repeatedly to killed sporozoites contain antibodies against 11 major
sporozoite antigens. Considerable research at ILRAD focuses on identifying and
characterizing these antigens and determining whether they might be used to stimulate
protective immune responses in cattle. The objective is to produce sporozoite antigens by
expression of the appropriate genes and to test them to determine their potential value in an
ECF vaccine.
One of these antigens, with an approximate molecular mass of 67,000 daltons, is a
glycoprotein, with antibody responses apparently stimulated by the protein moiety. Results
from several experiments suggest that it contains at least two sets of amino acids, called
epitopes, which stimulate the production of neutralizing antibodies. Out of a panel of 17
monoclonal antibodies raised against the 67,000-dalton protein, two appear to recognize
different epitopes. Used in combination, they neutralize sporozoites better than when used
singly. The identification of more than one protective epitope will be important in the design of
a peptide vaccine.
The purified 67,000-dalton protein was used in 1987 to raise monospecific antisera in rats. The
antisera recognized the 67,000-dalton protein and also recognized the surface of live
sporozoites and neutralized their infectivity. These results confirm earlier findings that the
67,000-dalton protein is located on the surface of the sporozoite and that it is responsible for
stimulating neutralizing antibodies.
Further studies were conducted in collaboration with Wistar Institute (USA) to determine the
total amino acid composition of the 67,000-dalton protein. The enzyme trypsin was used to
break the protein down into peptides, these were separated by high-performance liquid
chromatography (HPLC) and their amino acid composition and sequences were analysed. Six
peptide sequences have now been determined.
In order to identify the genes which encode protective sporozoite antigens, both genomic and
cDNA (copy DNA) libraries have been constructed and screened with antisera from cattle
immunized with killed sporozoites. A cDNA clone was obtained which contained a 207 base
pair insert from which an amino acid sequence could be inferred. This sequence was identical
to the sequence of 24 amino acids contained in one of the peptides recently obtained in
collaboration with the Wistar Institute.
The cDNA clone hybridized to DNA from piroplasms and/or schizonts of T p parva Muguga,
Marikebuni, Mariakani, Pemba/Mnarani and Uganda, T p lawrencei and T p bovis, but not to
DNA from T annulata, T mutans or T taurotragi. This suggests that the gene is specific to the
species T parva but not to particular subspecies or stocks. Work now focuses on obtaining the
entire sequence of the gene that encodes the 67,000-dalton antigen. The next step will be an
attempt to produce this antigen as an expressed product of the gene for vaccination trials.
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Another approach to the identification of genes encoding sporozoite antigens began with total
genomic DNA isolated from T p parva Muguga piroplasms. This was broken up by shearing
and the fragments inserted in the lambda gt 11 expression vector. When the resulting library of
cloned DNA fragments was screened with serum from a sporozoite-immunized cow, three
clones were identified that encoded different, unique sets of antigenic determinants. All of the
other Theileria-specific antigens identified on Western blots appear to be derived from these
three gene products. This suggests that the three cloned sequences may encode three
different proteins that exhibit most, if not all, of the major antigenic determinants found on or
inside the sporozoite.
Determination of the DNA sequence of one of these clones has shown that it contains the
entire coding region for a protein with a molecular weight of approximately 100,000 daltons as
well as some sequences preceding the gene that may represent a theilerial control or
promoter region. The presumed amino-acid sequence exhibits characteristics suggesting that
this protein could be a membrane component, though it has not yet been possible to
determine the location of the antigen on the surface or inside the sporozoite. The regions of
the gene that react with the anti-sporozoite antiserum have been subcloned and expressed
and the resulting peptides have been used to immunize cattle. Experiments are now in
progress to try to express the entire antigen in sufficient quantities for use in immunization
trials.
 Immunization with irradiated sporozoites
A study was initiated in 1986 on the effects of irradiation on T parva sporozoites. Early results,
using a sporozoite-binding assay and in vitro infection of lymphocytes, showed that irradiated
sporozoites bind and enter lymphocytes as efficiently as non-irradiated sporozoites, but within
the infected cells only a small proportion of irradiated sporozoites develop into schizonts.
Further experiments in 1987 showed that bovine lymphocytes could be induced to multiply in
vitro when infected with irradiated sporozoites, although initial cell growth was slow. When
lymphocytes were infected with irradiated sporozoites and examined by electron microscopy 1
week later, 20 to 30% of the cells contained immature or damaged schizonts, whereas
lymphocytes which had been infected with non-irradiated sporozoites contained normal
schizonts (Figure 5). Both irradiated and non-irradiated sporozoites transformed lymphocytes
into dividing lymphoblasts and, once cell lines were established, growth and infection rates
were similar.
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Figure 5. Electron micrographs of Theileria parva Muguga sporozoites entering bovine
lymphocytes and developing into schizonts 1 week later. Both irradiated (A) and non-irradiated
(B) sporozoites (Sp) are capable of entering bovine lymphocytes (L) in similar numbers.
However, the development of irradiated sporozoites (C) into schizonts (Sc) during the first
week after infection is abnormal, compared to the development of schizonts from non-
irradiated sporozoites (d).
The early development of irradiated sporozoites after entry in the host cell is now being
studied in more detail. Cells infected with irradiated sporozoites are also being cultured with
cytolytic T lymphocytes specific for T parva-infected cells. Any cell killing observed in these
cultures could shed light on possible host immune responses to infected cells.
 Bovine immune responses and schizont-infected cells
The third major component of ILRAD's theileriosis research program concentrates on the
schizont stage of parasite development. When cattle develop immunity to ECF—either
following natural infection and recovery or after immunization by infection and treatment—
there is evidence that cytolytic (cell-killing) T lymphocytes are stimulated specifically to kill
Theileria-infected cells. By contrast, when susceptible cattle become infected, cytolytic T cells
are stimulated which are capable of killing both infected and uninfected cells. This non-
specific cell killing is probably involved in the destruction of the immune system which is a
prominent feature of acute infection. Thus cell-mediated immune responses appear to play an
important role both in immunity to ECF and in the pathology of the disease.
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An immune response is initiated when one subpopulation of T lymphocytes recognizes
antigens associated with `foreign' disease agents. These helper T lymphocytes do not
recognize antigens in isolation, but only when they are presented on the surface of specialized
cells, known as antigen-presenting cells. The helper T cells then become activated and
produce soluble factors which enable other cells of the immune system to mount a protective
immune response. The second, effector, stage of the immune response can be mediated by
cytolytic T lymphocytes in the case of cell-mediated immunity, or by B lymphocytes which
produce antibodies.
Studies continued in 1987 on the complex process of immune responses to schizont-infected
cells, from the first recognition of the infected cell as a 'foreign' body to its destruction by
cytolytic T cells. Work focuses on identifying the antigenic changes displayed by
schizontinfected cells which stimulate cell-mediated immunity. The primary objective is to
develop improved immunization procedures based on schizont-associated antigens which will
protect cattle against ECF.
Another objective is to gain a better understanding of immune responses in cattle which could
lead to new methods for enhancing resistance to ECF and other diseases. This work has
involved the development of techniques and reagents for identifying bovine cell types involved
in immunity. Another aspect is research on the bovine major histocompatibility complex—MHC
—a group of genes encoding molecules which play a central role in the presentation of
antigens to cells of the immune system.
 Proliferation of infected cells
An understanding of how Theileria parasites regulate the growth of host cells might lead to
new methods for treating infected animals or attenuating the parasites and making them more
vulnerable to destruction by the host immune system. Earlier research on the proliferation of
Theileria-infected T lymphocytes showed that some infected cells secrete a molecule of
25,000 daltons which shares several characteristics with the bovine T-cell growth factor,
interleukin 2 (IL-2). Work has concentrated on the possible role of IL-2 in maintaining the rapid
cell proliferation which is an important feature of ECF infection.
A human IL-2 cDNA hybridization probe was used to screen messenger RNA (mRNA) from
infected and uninfected cells originating from cloned T-cell lines. Experiments are now in
progress to assess the levels of IL-2-specific mRNA in these cell lines using a bovine genomic
DNA probe and a new oligonucleotide probe provided by Johns Hopkins University (USA).
Studies in collaboration with the Kernforschungszentrum laboratory in Karlsruhe (FR
Germany) are exploring the possible role of transformed cell-membrane molecules in
stimulating and maintaining proliferation of Theileria-infected cells. Some of the genes which
encode cell membrane receptors for hormones and growth factors have similarities with
oncogenes—genes introduced by viral infections and implicated in the transformation and
growth of cancer cells. By screening DNA from Theileria-infected and uninfected bovine cells
for genes whose transcription is enhanced during infection, scientists identified an oncogene
which appears to be associated with Theileria infection. Subsequent screening with a viral
oncogene DNA probe revealed consistent differences in DNA from bovine cell lines before and
after infection with different stocks of T p parva.
When oncogenes stimulate cells to multiply, enzymes called protein kinases trigger the
attachment of phosphates to protein substrates through a process called phosphorylation.
Characterization of kinase activity during Theileria infection has shown a considerable
increase in phospho-proteins in infected cells compared with their uninfected parent clones.
Current efforts are directed towards identifying the genes which encode protein kinases and
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purifying and characterizing the host-cell substrates for kinase activity.One objective is to test
the possible role of protein kinases in host-cell transformation and induction of immune
responses by transfecting the genes which code for protein kinases into quiescent bovine
lymphoid cells.
 Immune responses to schizont-infected cells
There is substantial evidence that the cell-mediated immune responses which play an
important role in immunity to ECF are directed specifically against antigenic changes on the
surface of parasitized cells. Previous work has also shown that cytolytic T-cell responses are
restricted by MHC molecules on the surface of host cells: they kill infected cells from the same
ani mal and from animals of matched MHC type, but not infected cells from animals of
different MHC types. This indicates that the cytolytic cells recognize parasite-induced
antigenic changes on the surface of parasitized cells in conjunction with host MHC molecules.
However, it has not yet been possible to identify the target antigens on the cell surface.
 Strain specificity
Studies with T-cell clones in 1986 showed that both helper and cytolytic T lympho cytes
participate in the parasite-specific immune response and that in some circumstances both
types of T cell exhibit parasite strain specificity. In 1987, scientists continued to analyse the
specificity of the cytolytic T cell response, both in vivo and using cloned cell lines in vitro. The
principal aims are to determine whether the specificity of T-cell responses to individual
parasite strains correlates with the strain specificity of responses observed in immunized cattle
and to provide reagents that can be used to help identify the antigens on the surface of
parasitized cells which stimulate immunity.
Studies on cytolytic T lymphocytes have concentrated on the Muguga and Marikebuni stocks
of T p parva. These stocks were selected because cattle immunized with the Marikebuni stock
are protected against challenge with both stocks of the parasite, whereas a proportion of cattle
immunized with the Muguga stock succumb to challenge with Marikebuni. Cytolytic T cells
generated in all cattle immunized against T p parva Marikebuni kill target cells infected with
either of the two parasite stocks. Cytolytic T cells derived from some cattle immunized against
the Muguga stock only kill target cells infected with Muguga, whereas cells derived from other
cattle immunized against Muguga also kill some cells infected with Marikebuni. There is
preliminary evidence that these differences may be associated with differences in MHC type
among individual animals. These results are consistent with results from cross-immunity
testing in cattle and provide evidence for the importance of the cytolytic T-lymphocyte
response in immunity.
Experiments conducted in 1987 indicated that cellular immune responses in buffalo are similar
to those in cattle: both proliferative and cytolytic responses appear to be parasite specific and
MHC restricted. To investigate strain specificity, T lymphocytes were derived from a buffalo
infected with T p lawrencei and stimulated in vitro with cloned infected cells derived from the
same animal. These cells were then assessed for cytolytic activity against cells lines derived
from the same animal and infected in vitro with five different T p lawrencei stocks. Screening
with ILRAD's panel of monoclonal antibodies had indicated that these cell lines were all
antigenically distinct. However, the cytolytic buffalo cells killed all the infected cells lines,
suggesting either that the infected buffalo had generated cytolytic cells against a variety of
antigens or perhaps that the different parasite stocks shared antigens in common. This work
was conducted in collaboration with the Kenya Government's Veterinary Research Laboratory,
partially supported by the Government of The Netherlands.
It is not possible to obtain definitive results on strain-specific immunity using uncloned T
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lymphocytes from immunized animals because uncloned lymphocytes may include mixed
populations of T cells which differ in their parasite strain specificity. Clear results can only be
obtained using cloned cells. Thus, cytolytic T lymphocyte clones have been derived from cattle
immunized with either T p parva Muguga or T p parva Marikebuni. The target cell lines used in
these experiments were cloned by limiting dilution following infection with Theileria sporozoites
and thus probably contained cloned parasites.
Clones generated against the Marikebuni stock killed target cells infected with either of the two
stocks, whereas clones generated initially against the Muguga stock only killed target cells
infected with T p parva Muguga. These findings suggest that cloned T lymphocytes derived
from cattle immunized with T p parva Muguga or Marikebuni recognize two different sets of
antigenic determinants, one of which is shared between the two parasite stocks. In
subsequent studies the Muguga-specific cytolytic T-cell clones also killed some of the target
cell lines infected with Marikebuni. This may reflect heterogeneity of parasites within the
Marikebuni stock. Further work is now being undertaken to determine whether the responses
of helper T lymphocytes are also parasite strain specific.
 Antigenic changes on infected cells
Considerable research is in progress to identify the antigenic determinant(s) on schizont-
infected cells which are recognized by Theileria-specific T lymphocytes. Such antigen(s) might
provide the basis for a vaccine against this stage of the parasite.
Several monoclonal antibodies are available at ILRAD which recognize T parva schizont
antigens but none reacts with the surface of infected cells. Interestingly, many of these
monoclonal antibodies appear to recognize the same protein in infected cells, suggesting that
this molecule is dominant in the induction of antibody responses. Some of the monoclonal
antibodies recognize different epitopes on the protein molecule which are specific to particular
parasite stocks. The protein also differs in terms of molecular weight between stocks and
between different cloned parasitized cell lines derived from the same stock (Figure 6).
Preliminary results indicate that this protein is present in purified sporozoites as well as
schizonts. Experiments are in progress to purify the protein and test its capacity to stimulate
Theileria-specific T lymphocytes. Research in this area also includes efforts to produce
monoclonal antibodies against other schizont-associated molecules.
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Figure 6. Western blots derived from Theileria-infected cells incubated with a monoclonal
antibody which recognizes a schizont antigen. Clear differences are detected in the molecular
weight of the molecule recognized by the monoclonal antibody, both between parasite stocks
and between parasite populations derived from the same stock. Lane 1 shows the antigen
detected by the monoclonal antibody in a cell line infected with T p parva Muguga. Lanes 2 to
5 show the antigens detected by the same monoclonal antibody in different cell lines, all
infected with T p parva Marikebuni.
Other experiments involve breaking up infected cells and testing different cell components for
their capacity to stimulate the proliferation of parasite-specific helper T lymphocytes. Initial
results have shown T-cell stimulation by membrane and soluble fractions derived from T
parva-nfected lymphocytes and by schizonts purified from infected cells, but not by similar
fractions prepared from uninfected lymphocytes stimulated to proliferate by the mitogen
concanavalin A. Both soluble and membrane fractions induce proliferation only in the presence
of irradiated accessory or antigen-presenting cells from MHC-matched cattle. This ability of
parasitized cells to stimulate both proliferative and cytolytic responses is lost a few days after
treatment with the anti-theilerial drug parvaquone, indicating that the stimulation of cell-
mediated immune responses requires the active participation of the parasite within the infected
cell.
Current work concentrates on purifying the antigens present in the soluble fraction and
generating helper T-cell clones and antibodies which recognize these antigens. Monospecific
antibodies will then be used to screen Theileria DNA libraries in order to identify the genes
which encode antigens that stimulate helper T-cell proliferation.
Although cytolytic T lymphocytes are readily generated which recognize schizont-infected
cells, it has not yet been possible to stimulate cytolytic T cells with crude preparations of
antigens from purified schizonts. Studies on T-cell responses in other species have shown
that cytolytic T lymphocytes generally do not respond to proteins that have been internalized
and processed by antigen-presenting cells.Thus, in order to test whether a specific parasite
antigen will trigger a cytolytic T-cell response it may be necessary to identify the gene which
encodes the antigen and transfect it into a noninfected cell. Transfection involves the
introduction and integration of cloned DNA sequences into a recipient genome and their
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consequent expression.
If cells transfected with parasite DNA are to be recognized by cytolytic T lymphocytes, they
must also express the appropriate bovine class I MHC antigens. Unfortunately, no cell of this
type is available which is suitable for transfection. For this reason, present work concentrates
on transfecting bovine MHC genes into mouse fibroblast cells which are known to be suitable
recipients for foreign DNA. Once cells expressing the appropriate bovine class I gene are
obtained, these will be used as recipients for parasite genes.
Studies carried out in 1987 have shown that biologically active mRNA can be isolated from
purified Theileria schizonts. In the coming year, a cDNA library will be prepared from schizont
mRNA and screened, along with existing Theileria genomic DNA libraries, with polyclonal
antisera and ILRAD's panel of anti-schizont monoclonal antibodies to identify genes which
encode schizont antigens and which may prove suitable for transfection. To help anticipate
potential problems in transfecting parasite DNA into mammalian cells, a cloned Theileria gene
obtained from genomic DNA and encoding a sporozoite antigen will be transfected into mouse
cells.
 Characterization of bovine cell types
Studies of both cellular and humoral immune responses in cattle require techniques to identify
the different cell types which play a role in immunity. In general terms, humoral immune
responses involve the production of antibodies by B lymphocytes produced in the bone
marrow, while cell-mediated immune responses are mediated by T lymphocytes which mature
in the thymus. However, both types of immune response are highly complex processes which
involve more than one cell type.
 Cells types involved in immunity
Monoclonal antibodies have been raised at ILRAD which recognize all T lymphocytes, the
subpopulation of T lymphocytes which function as helper cells, stimulating other cells to mount
an immune response, and the subpopulation of T lymphocytes with a cytolytic function aimed
specifically at cells infected with Theileria schizonts. The target molecule recognized by one of
ILRAD's monoclonal antibodies on the surface of all T lymphocytes has been designated
BoT2, whereas the target molecule recognized specifically on helper T cells is called BoT4
and the molecule recognized on cytolytic T cells is BoT8. Work in this area in 1987
concentrated on completing the definition of these and other monoclonal antibodies produced
at ILRAD and further investigating the functional properties of the cells they recognize.
Additional monoclonal antibodies are also being sought which will distinguish subgroups within
the two functionally important T-lymphocyte populations displaying the BoT4 or the BoT8
molecule.
Several monoclonal antibodies have been raised which react with a different molecule on
mature bovine T lymphocytes. a protein of 130,000 daltons. The monoclonal antibodies which
recognize this molecule appear to stimulate proliferation of bovine T cells, suggesting that the
molecule has an important function in the activation of T lymphocytes in cattle.
In collaboration with the Agriculture and Food Research Council's Animal Disease Research
Institute at Compton (UK), ILRAD has gained access to two monoclonal antibodies that
recognize not only T cells expressing BoT2 and BoT4 or BoT8, but also a small, distinct
population of lymphocytes lacking these markers. Monoclonal antibodies have been produced
which react specifically with these null lymphocytes. These cells appear to originate in the
thymus, but have a distinctly different tissue distribution from conventional T cells (Figure 7).
They proliferate strongly in mixed reactions of white blood cells and also proliferate in
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response to the T-cell mitogen concanavalin A when also in the presence of T-cell growth
factors. Several other research groups have produced monoclonal antibodies which appear to
recognize the same or similar cells and in all instances the antibodies react with cells from
both sheep and cattle. ILRAD scientists are collaborating with colleagues in Australia,
Switzerland and the UK to elucidate the functional properties of these cells.
Figure 7. Frozen sections of normal bovine lymph nodes stained by the immunoperoxidase
technique with monoclonal antibodies that react with (A) all T lymphocytes and (B) a
population of non-T, non-B lymphocytes.
ILRAD now has five monoclonal antibodies which react with granulocytes and
monocytes/macrophages, including the large, frilly macrophages in afferent lymph which
appear to be distinct from monocytes and mature macrophages in the blood. Several other
monoclonal antibodies are being examined which react with dendritic cells or with dendritic
cells plus B lymphocytes. Many of these reagents also react with cells in the bone marrow.
Scientists are investigating the functional significance of these different cell types in antigen
presentation. There is an increasing body of evidence that the large, frilly macrophages in
afferent lymph play a role in transporting antigen to the lymph node and presenting it to helper
T lymphocytes. The antigen is not presented to the helper T cells in its native form, but as
processed peptide fragments associated with MHC molecules on the cell surface.
Cannulation techniques have recently been developed which make it possible to collect
afferent lymph from cattle for periods of up to 14 days. Preliminary investigation of the frilly
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cells in these samples of afferent lymph (Figure 8) indicates that they present soluble
antigens, such as the variable surface glycoproteins (VSGs) of trypanosomes, to primed T
lymphocytes with great efficiency. Experiments are now in progress to obtain VSG specific T-
cell clones which can be used to study the efficacy of antigen presentation by these frilly cells
in more detail and determine whether different subpopulations of T lymphocytes are stimulated
preferentially by specific populations of antigen-presenting cells. The processing of antigen
within these cells will also be investigated, as well as their capacity to transport antigen to
specific sites within the lymph node.
Figure 8. Electron micrograph of a frilly cell from a sample of afferent lymph collected by
cannulation procedures from a normal Boran calf.
Of the five monoclonal antibodies raised at ILRAD against monocytes/macrophages and
granulocytes, two react with all of the frilly cells, two react with a subpopulation of the frilly
cells and one does not react with the frilly cells. Additional monoclonal antibodies are now
being raised specifically against these cells.
 Cell types infected with Theileria
Previous studies have shown that both B and T lymphocytes can be infected in vitro with T
parva, but in mixed cell populations T cells invariably overgrow B cells so that in a short time
the cultures contain virtually all T cells. Among T lymphocytes, both helper cells displaying the
BoT4 molecule and cytolytic cells displaying the BoT8 molecule are readily infected and
generally retain the antigenic determinants expressed before infection.
Null lymphocytes can also be infected and after infection some of these cells acquire T-cell
surface markers. Acquisition of different T-cell antigens varies somewhat according to the T
parva stock used to initiate infection. By contrast, B cells infected with T parva do not acquire
any T-cell markers; a proportion of infected B cells continues to express surface antibody
(usually IgM) for periods of several weeks or months after infection Monocytes and neutrophils
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cannot be infected.
Most parasitized cells derived from infected cattle are T lymphocytes. In order to assess the
role of different cell types in Theileria infections in cattle, different cell types were derived from
cattle, infected with T p parva Muguga in vitro, cloned and inoculated back into the original
animals. Only one of the cattle inoculated with infected B lymphocytes developed detectable
infection and some of the animals in which parasites were not detected remained fully
susceptible to subsequent challenge with the same parasite stock. By contrast, all the cattle
inoculated with T lymphocytes or null lymphocytes developed detectable—though mostly mild
—infections and all resisted subsequent challenge. These results confirm earlier observations
that B lymphocytes probably do not play a major role in the pathogenesis of T parva infections
in cattle. The mild reactions observed in these experiments are in marked contrast to the
severe infections observed in cattle inoculated with their own cells infected in vitro but not
cloned. This suggests either that with continued culture in vitro parasitized cells become less
well adapted to growth in cattle or that different parasitized cell types complement each other's
cell growth in infected animals.
An experiment was conducted in 1987 to determine whether differences in immune responses
might relate to the specific cell type infected with Theileria. Peripheral blood cells were sorted
into separate populations of helper and cytolytic T lymphocytes and both groups were infected
with Theileria sporozoites. However, when the two groups of infected cells were incubated with
Theileria-specific cytolytic T lymphocyte clones, no differences in levels of cell killing were
observed.
 Studies on the bovine MHC
A group of genes—known as the major histocompatibility complex or MHC—has been found
in all mammalian species studied. These genes play an important role in the induction of both
humoral and cellular immune responses. Significantly, both helper and cytolytic T lymphocytes
can only detect foreign antigens in association with the glycoprotein products of host MHC
genes. The MHC gene products fall within two major groups, called class I and class II, which
are distinguished on the basis of their molecular nature, function and cellular distribution.
These products—the MHC antigens—are integral components of cell membranes.
Research on the bovine MHC at ILRAD has concentrated in four areas. These are the
development of improved techniques to type individual cattle according to class I and class II
MHC genes and their products, studies on the structure of the MHC and the complex
relationship of individual genes to the MHC antigens expressed on the surface of bovine cells,
research on the role of the bovine MHC in immune responses to Theileria and more recently,
in collaboration with ILCA and the International Trypanotolerance Centre in The Gambia,
preliminary studies on the role of the bovine MHC in resistance to trypanosomiasis.
In September 1987, ILRAD held a workshop to discuss recent advances in research on the
class II MHC, primarily in livestock but also in laboratory animals and man. The objectives
were to assess the state of knowledge on the class II region in cattle and to identify ways in
which work in cattle may be advanced in the light of experience in other species. The
participants also discussed ways in which the association between disease resistance and
MHC type might be identified.
 Characterization of cattle according to MHC type
Cattle are typed serologically at ILRAD according to MHC antigens, using a panel of over 180
antisera and 20 monoclonal antibodies which react with determinants of MHC gene products.
The majority of these reagents react with the products of class I MHC genes. Efforts to
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improve class I MHC typing has focused primarily on two areas—accurate assessment of
typing reaction and the handling and storage of large amounts of typing data. More than 2000
cattle have been typed with the full panel of reagents using a computer-controlled automated
typing system developed at ILRAD. A program for the storage and analysis of bovine MHC
data has been written by scientists at ILRAD in collaboration with colleagues at the University
of Strathclyde (UK). It is called BOLA-PC and is now being used in laboratories in Denmark,
Italy, the UK and the USA. Researchers have rapid access to information on the pattern of
antisera reactivity for any animal tested, plus other information including parentage, breed,
age and disease status.
Among the typing reagents, monoclonal antibodies have considerable advantages over
conventional typing alloantisera. So far, more than 20 mouse monoclonal antibodies have
been produced at ILRAD which recognize different bovine class I MHC antigens. These are
now being used for MHC typing in laboratories in France, Germany (FR), Great Britain, Italy,
Norway, Switzerland and the USA. They have also proved indispensable in various
biochemical and cellular studies of the bovine MHC. Scientists from ILRAD and from the
Agriculture and Food Research Council's Institute of Animal Physiology and Genetics
Research in Cambridge (UK) have also produced the first bovine monoclonal antibody which
reacts with a class I determinant in cattle.
Using both alloantisera and monoclonal antibodies, ILRAD scientists have completed a
comparative analysis of class I MHC phenotypes for more than 1400 cattle of diverse origin.
This work was carried out in collaboration with colleagues at the Institute of Animal Physiology
and Genetics Research in Edinburgh (UK). Figure 9 illustrates results for West African
N'Dama cattle (Bos taurus) which display resistance to trypanosomiasis, East African Boran
(Bos indicus) and European taurine cattle of various breeds. The frequencies of some MHC
types were clearly different among the different populations (e.g. KN18), whereas the
frequencies of other MHC types were remarkably similar for all the animals tested (e.g. W10).
Where differences occur between African and European breeds, these may be the result of
natural selection operating in different disease environments. If this is the case, the results of
surveys such as the one described suggest which MHC types are particularly advantageous in
a specific environment. Such types are promising candidates for further laboratory study and
disease-challenge experiments to identify individual genes associated with superior disease
resistance.
The typing of cattle according to class II MHC antigens is not as straightforward as typing
according to class I. However, three methods are being pursued which may prove useful. The
first involves attempts to produce monoclonal antibodies specific for bovine class II antigens.
The second is based on measuring proliferative responses when lymphocytes from two
different animals are mixed together. T lymphocyte clones have been produced at ILRAD
which proliferate in response to specific antigens on the surface of lymphocytes from different
animals. These are proving to be a discriminating and powerful tool for typing cattle according
to class II MHC antigens. The third method is based on the analysis of specific DNA
sequences contained in and around MHC genes. This work is being undertaken in
collaboration with scientists at the Swedish University of Agricultural Sciences and the Institute
of Animal Physiology and Genetics Research in Edinburgh.
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Figure 9. MHC class I gene frequencies in Boran, European and N'Dama cattle. Genes are
identified through characterization of their products which are prefixed and numbered.
The development of a practicable and reliable system for typing large numbers of cattle
according to class I MHC antigens, and selected individuals according to class II antigens,
now makes it possible to begin searching for associations between MHC types and resistance
to disease in African breeds. Such associations could provide the basis for future breeding
programs.
 Elucidation of MHC gene products
In cattle, it is now possible to distinguish about 30 different expression forms (called alleles) of
one class I MHC gene using antisera and monoclonal antibodies. These are all located at one
site on the chromosome—the A locus. Studies suggested that other class I gene products
may also be expressed in cattle. Recently, ILRAD scientists have found evidence for the
expression of class I MHC antigens at a second locus, the B locus. This was accomplished
using mouse and cattle monoclonal antibodies to study mutant lines of cattle cells lacking
expression of certain class I antigens and also using a mouse cell line transfected with a
bovine MHC gene. The MHC gene expressed at the B locus also expresses a number of
different antigenic forms, apparently independently of the forms expressed at the A locus.
Present efforts to overcome many of the difficulties inherent in class II MHC typing concentrate
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on the production of class IIspecific monoclonal antibodies. Work in this area involves
innovative approaches to monoclonal antibody production, including immunizing mouse B
lymphocytes in vitro, rather than immunizing mice in vivo, before deriving B cells. Scientists
are also trying to produce monoclonal antibodies from fusions of mouse and cattle cells. This
work is being conducted in collaboration with the Institute of Animal Physiology and Genetics
Research in Cambridge. In order to produce antibodies which respond to class II antigens,
mice are being immunized with mutant cell lines which are normal for class II expression but
deficient in class I expression.
 Mapping the bovine MHC
The availability of mutant cell lines with some MHC genes deleted has made it possible to
begin mapping the MHC region of the bovine genome. DNA from normal and mutant cell lines
has been digested into fragments with different restriction enzymes, and the fragments
separated by field inversion gel electrophoresis and screened with class I and class II DNA
probes. Large fragments of DNA are deleted from some mutant cell lines. By using several
restriction enzymes separately and in combination, it is possible to identify the genes
associated with these fragments, thus gradually constructing a simple map of the location of
MHC genes.
Using this technique, it has been estimated that class I and related MHC genes cover
approximately 1.6 million base pairs in the bovine genome. Class II genes appear to cover a
much shorter region. It is not possible to estimate the total size of the bovine MHC at present
because other genes lie between the class I and class II regions.
 Non-MHC histocompatibility antigens
In the course of studies on the bovine MHC, two monoclonal antibodies have been derived
which react with antigens on the white blood cells of cattle quite distinct from MHC antigens.
This antigenic system is now known to include at least four alleles, all described in various
Bos indicus and Bos taurus breeds including Boran and N'Dama. The functional significance
of this system is not known, but an awareness of its existence is important for the correct
interpretation of MHC typing data.
 Role of the MHC in immune responses to Theileria
Cytolytic T lymphocytes, taken from the blood of a cow following Theileria immunization or
challenge, are capable of killing Theileria-infected cells in vitro as long as the cells are derived
from the same animal and thus share the same MHC antigens. This phenomenon is known as
MHC restriction. Now that it is possible to determine the MHC types of experimental animals
at ILRAD, scientists have been able to demonstrate that the parasite-specific cytolytic
response generated in vivo is also predominantly restricted by the MHC.
The important role of the MHC in cellular immune responses against Theileria parasites has
been confirmed by patterns of reactivity in vitro between panels of target and responder
(effector) cells which are partially or fully identical in terms of MHC: immune responses occur
only when the target and responder cells are matched for an appropriate MHC product.
Restriction by either class I or class II MHC has been observed: the cell-killing or
proliferative/helper functions of T lymphocytes are inhibited when class I or class II MHC gene
products are neutralized by adding the appropriate monoclonal antibodies to in vitro assays.
Thus it appears that T lymphocyte responses in cattle undergoing immunization or challenge
with T parva are typically MHC restricted, with many similarities to the well characterized T-cell
responses to viral antigens in mouse and man.
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ILRAD scientists have obtained evidence that the strain specificity of cytolytic T-cell responses
to Theileria-infected cells may be influenced by MHC type. In 1986, T lymphocytes derived
from two cattle immunized with T p parva Muguga killed target cells infected with the Muguga
stock, but not with T p parva Marikebuni. These T-cell responses were restricted by two class
I MHC alleles—w10 and KN18. In 1987, cytolytic T cells derived from two different cattle
immunized with T p parva Muguga killed target cells infected with either the Muguga or the
Marikebuni stacks at similar levels. T cells from both these animals were restricted by the w6.2
class I MHC allele. These findings suggest that an animal's MHC type may determine which
parasite-induced antigen becomes the target for cell-mediated immunity, thus determining the
strain specificity of the response.
To explore this possibility further, scientists are conducting an immunization and challenge
experiment with groups of cattle of defined MHC types. A limiting dilution assay has been
developed to determine the frequencies and specificities of cytolytic T lymphocytes in animals
immunized with T p parva Muguga prior to challenge with T p parva Marikebuni. Thus it
should be possible to compare the strain specificity of cytolytic T cells in vitro with MHC type
and with the subsequent strain specificity of the immune response.
 Embryo transfer to produce cattle of specified MHC types
An important aspect of ILRAD's MHC research program has been the application of embryo
transfer techniques to provide cattle which are full siblings or identical twins of specified MHC
types. Hormonal treatment regimes have been developed for inducing superovulation , and
synchronizing oestrus among donor and recipient animals in ILRAD's breeding herd of Boran
cattle. Using these techniques, approximately 60% of cows respond to superovulation, yielding
an average of 3.7 embryos each. Surgical transfer of these embryos gives a pregnancy rate of
63%.
By the end of 1987, seven sets of identical twins had been produced by embryo splitting and
transfer of demi-embryos into separate recipients. One set of identical twin calves is now
being used to investigate the possibility of conferring immunity against Theileria infection by
inoculating a naive animal with Theileria-specific T cells generated from its immunized twin.
Using conventional breeding and embryo transfer, ILRAD has obtained 12 cattle, representing
five MHC types, which are homozygous over the MHC region. These animals possess
identical MHC genes inherited from both parents. They provide an important research
resource which considerably simplifies studies on the structure and function of the MHC
region.
 Exploring vaccine delivery systems
If Theileria sporozoite or schizont antigens are identified which appear to stimulate protective
immunity against ECF, the best methods for eliciting the appropriate immune responses in
cattle must be determined in order to develop an effective vaccine. For this reason,
experiments were initiated in 1987 to explore different antigen delivery systems for inducing
humoral or cell-mediated immune responses in cattle. This work has concentrated on two
areas: the characterization of antigen-presenting cells in afferent lymph and the development
of transfection techniques. Both have already been discussed in different section of this report.
Experiments to establish transfection techniques have started by transfecting bovine class I
MHC genes from genomic DNA into mouse fibroblast cells. The approach is to break up
bovine genomic DNA by shearing, transfect the fragments into mouse cells and select cells
expressing bovine class I MHC molecules using specific monoclonal antibodies with a
fluorescence-activated cell sorter (FACS). To date, one transfectant expressing a bovine class
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I molecule has been selected and cloned. Transfected cells will be useful not only for isolating
different class I gene products, but also potentially for transfecting Theileria genes. Work in
1988 will concentrate on extending transfection techniques to bovine cells.
Studies on recombinant vaccinia viruses will also begin in 1988. The aim of this work will be to
explore the potential of recombinant viruses as a means of presenting parasite antigens to
cattle for induction of protective immunity.
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Trypanosomiasis is a disease complex caused by several species of blood-and tissue-dwelling
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protozoan parasites. The disease occurs throughout the tropical regions of Africa and in large
areas of Asia and South America. It affects cattle, sheep, goats, pigs, horses, camels and
man. Wild animals can also be infected with the parasites but generally do not suffer from
disease. They are the source (reservoir) of infection for domestic animals.
The most important trypanosome species affecting domestic livestock in Africa are
Trypanosoma congolense, T vivax and T brucei brucei in cattle, sheep and goats, T simiae in
pigs and T evansi in camels. T vivax also has a significant impact on cattle production in
South America, while T evansi affects camels in Asia and horses, cattle and domestic buffalo
in South America, India and Southeast Asia. The human disease is caused by T brucei
gambiense and T b rhodesiense.
African trypanosomes are transmitted from the reservoir hosts to livestock by several species
of tsetse flies and also by other biting insects. Infected animals develop fever, lose weight and
progressively become weak and unproductive; breeding animals may abort or become
infertile. Left untreated, many animals die of anaemia, heart failure or intercurrent bacterial
infections that take advantage of the animal's weakened resistance. Highly productive exotic
breeds tend to be especially susceptible. In man, a similar course of events takes place with
parasites ultimately invading the brain, resulting in the disease syndrome known as `sleeping
sickness'.
In Africa, trypanosomiasis occurs in 37 countries, extending over 10 million square kilometres
or roughly one-third of the continent. Throughout this region, an estimated 50 million cattle—
about 30% of Africa's total cattle population—are exposed to the risk of infection. Largely due
to the widespread incidence of trypanosomiasis, Africa produces about 70 times less animal
protein per hectare than Europe.
Control of trypanosomiasis is based primarily on insecticide spraying to control tsetse
populations and on regular treatment of livestock at risk with trypanocidal drugs. Rarely,
however, has complete control been achieved using these methods, even after substantial
effort. The high cost of regular drug and insecticidal treatment, the limited effectiveness of
insecticide application in high-rainfall areas, the possibility of environmental pollution by
insecticides, the increasing incidence of parasite resistance to available drugs and the
absence of new drugs to replace them—these are some of the problems that make tsetse and
trypanosomiasis control difficult and expensive. What's more, the disease problem may be
increasing with the expansion of areas infested by tsetse flies. There is an urgent need not
only to improve existing control methods, but equally importantly to seek new methods for
trypanosomiasis control.
This search will require intensive research into several aspects of the basic biology of the
parasites, the role of tsetse flies in transmitting disease and the responses to infection of
different breeds and species of livestock. The goal is to achieve a fuller understanding of the
entire disease process in order to identify promising avenues for practical immunological,
chemical or genetic control.
 Trypanosome biology and biochemistry
The three major tsetse-transmitted trypanosome species pass through several different stages
during their life cycle in both the insect vectors and the mammalian hosts. When a tsetse fly
feeds on an infected animal, it ingests trypanosomes along with blood. The parasites undergo
a cycle of development within the tsetse, passing through procyclic and epimastigote stages
and finishing as animal-infective metacyclic forms. When the infected fly next feeds, infective
metacyclic trypanosomes are injected into the skin of a mammalian host along with tsetse
saliva.
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When T congolense or T brucei parasites are transmitted to a susceptible animal by a tsetse
fly, a local skin reaction several centimetres in diameter—called a chancre—may develop at
the site of the bite. The metacyclic trypanosomes develop further in the chancre, invade the
local lymph vessels and move through the regional lymph node into the bloodstream. T vivax
parasites also move from the skin through the lymphatic system to the bloodstream, but the
local skin reaction, if it occurs, is less severe.
Infection in the bloodstream is characterized by successive waves of parasitaemia as
trypanosome populations multiply rapidly, then most of the parasites die, but a few survive and
begin multiplying again. T brucei parasites may also be found in the connective tissues and, in
later stages of infection, all three trypanosome species may invade the central nervous
system.
Metacyclic trypanosomes and the forms which develop in the mammalian bloodstream have a
thick coat which covers the entire surface of the parasite. The surface coat is composed of
glycoproteins referred to as variable surface glycoproteins or VSGs (Figure 10). The procyclic
and epimastigote forms which develop in the tsetse are not coated with VSGs until they reach
the metacyclic stage, ready for transmission to a mammalian host.
Figure 10. The molecular structure of a trypanosome VSG. A chain of amino acids is linked at
the C-terminal to a carbohydrate which contains an element, called the cross-reacting
determinant, that appears to be identical for a wide range of trypanosomes. One or more
additional carbohydrave(s) is linked to the amino acid chain. The carbohydrate containing the
cross-reacting determinant is part of a glycolipid which also includes two molecules of myristic
acid. These are thought to anchor the VSG in the membrane of the cell.
When an animal becomes infected, it produces antibodies against the VSGs displayed by the
first wave of invading trypanosomes. However, before all the parasites can be eliminated, new
trypanosomes emerge, coated with different VSGs, which are not recognized by the animal's
initial immune response. These trypanosomes multiply rapidly and the host produces new
antibodies, but then parasites appear with yet another VSG, always keeping a step ahead of
the host response.
This remarkable ability to change the biochemical and antigenic composition of the surface
coat—called antigenic variation—is the primary mechanism which prevents most domestic
animals from developing effective immunity against trypanosomiasis. The same mechanism
would enable the parasite to evade a conventional vaccine based on priming the antibody
responses against one or a small number of variable antigens.
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In 1987, several studies at ILRAD focused on genetic and biochemical changes which occur
when a trypanosome passes from one developmental stage to another, a process called
differentiation. Work also concentrated on various aspects of trypanosome metabolism and on
the mechanisms of antigenic variation. The goal of ail these studies is to identify factors which
could be manipulated to disrupt trypanosome development or to make the parasites more
vulnerable to host defences.
 Changes associated with the trypanosome life cycle
As trypanosomes develop in tsetse and mammals, different genes are expressed at different
stages of development. Research is in progress to identify such genes, define the elements in
the parasite genome which regulate their expression and determine how changes in gene
regulation take place.
All the genetic material contained in a trypanosome or other organism is present in the DNA,
located primarily in the cell nucleus. However, only a small proportion of genes present in the
DNA is expressed at any one time. These expressed genes are transcribed to mRNA and
translated into protein. A cDNA library constructed from mRNA obtained at a given stage of
parasite development should contain only those genes transcribed at that particular stage.
ILRAD scientists have constructed cDNA libraries using as templates mRNA from
bloodstream, procyclic and metacyclic forms of T congolense. Libraries from the different
stages are being compared to identify genes which are present, or abundant, only at particular
stages. Several mRNA transcripts are now being analysed which are specific to bloodstream
or metacyclic parasites. The objectives are to identify the nature and function of the proteins
encoded by stage-specific genes, the point at which stage-specific genes are switched on and
off and the mechanisms for regulating these genes.
A study was initiated in 1987 to characterize the respiratory metabolism of metacylic
trypanosomes. Trypanosomes use two distinct pathways for respiration in the different
environments of the tsetse and the mammalian bloodstream. In the bloodstream, respiration is
entirely dependent upon the trypanosome alternative oxidase (TAO), a mitochondria
glycerophosphate oxidase which is unique to trypanosomes and might provide a prime target
for trypanocidal drugs.
Procyclic trypanosomes utilize a mitochondria) cytochrome electron transport system for 70 to
80% of respiration and the TAO for only 20 to 30%. Work in 1987 showed that metacyclic
parasites also use both systems, but with the emphasis in reverse—20 to 30% mitochondria
cytochrome electron transport and 70 to 80% the TAO—indicating that metacyclic forms are
an intermediate differentiation stage between procyclic and bloodstream parasites. Further
experiments concentrate on a detailed analysis of the TAO and the mechanisms involved in
switching from one system to the other.
 Growth and transformation of bloodstream forms
Most populations of T b brucei in the mammalian bloodstream change from rapidly dividing to
nondividing forms. The nondividing trypanosomes are not infective for mammals; they may
represent an adaptation for transmission to the tsetse vector. Attention focuses on this
transition because parasite populations which switch more quickly to nondividing forms appear
to produce lower levels of parasitaemia and may be more readily controlled by the host than
parasites which remain in a rapidly dividing state. Studies in mice have indicated that host
factors may play a role in regulating the transition process: identical, cloned parasite
populations switch to nondividing forms more rapidly in mice which are resistant to
trypanosome infection than in susceptible mice.
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Molecular biologists are screening cDNA libraries from populations of the two T b brucei
bloodstream forms to identify any genes which are switched on specifically during the
nondividing stage of parasite development. Such genes might be involved in the negative
regulation of cell division. A comparison of cDNA libraries from dividing and nondividing
parasites led to the identification of two DNA sequences which appear to be specific for
dividing forms and nine sequences which may be specific for nondividing forms. Experiments
are now in progress to characterize the most promising of these sequences and to determine
their location within the trypanosome genome.
Once scientists have determined the location of stage-specific genes within the trypanosome
genome, it may be possible to identify DNA sequences associated with these genes which
play a role in controlling gene expression.
Because changes in protein structure have been shown to modulate cell differentiation in other
organisms, scientists at ILRAD are examining protein phosphorylation in the transition of T b
brucei from rapidly dividing to nondividing bloodstream forms. Two phosphorylated proteins
have been identified in nondividing trypanosomes which are not present in substantial
amounts in rapidly dividing forms. Scientists are now working to characterize these proteins, to
find the genes which encode them and to identify the enzymes (protein kinases) involved in
the phosphorylation process which may be associated with the transition from rapidly dividing
to nondividing trypanosomes.
Some T b brucei parasites do not appear to switch from rapidly dividing to nondividing
bloodstream forms, but continue dividing until death of the host. Early work suggested that
whether or not a parasite population switched to nondividing forms was an intrinsic trait of
specific parasite clones, though also influenced by host factors. However, research results
obtained in 1987 have challenged this view. When large numbers of one T b brucei clone
were used to infect mice, the parasites multiplied without remission until death of the hosts. By
contrast, when smaller numbers of the same parasites were injected into mice, populations of
bloodstream forms increased and then diminished. Scientists are now maintaining this T b
brucei clone in a cell-free culture system in order to investigate its multiplication and transition
to nondividing forms in more detail.
 Variable surface glycoproteins
Trypanosomes which develop in the bloodstream of an infected animal are capable of
expressing a very large number of different VSGs. Early studies showed that bloodstream
forms of T b brucei and T congolense can also express the same VSG a second time during
the course of infection. In 1987, ILRAD scientists obtained evidence suggesting that T vivax
bloodstream forms may also express the same VSG a second time. Cattle and goats infected
intravenously with a cloned population of T vivax bloodstream forms responded with
increasing antibody production 9 days after infection and again 16 to 21 days later,
presumably to the same VSG which had reappeared among the infecting parasites. To
continue these studies, techniques are now being established to measure more precisely the
immune responses against specific trypanosome VSGs.
Metacyclic trypanosomes are also capable of expressing a number of VSGs. Work is in
progress to determine how many different VSG genes are present in metacyclic forms of a
genetically identical parasite population (serodeme) and whether metacyclic VSG genes have
any peculiarities with respect to their activation or expression which might serve as targets for
intervention. Specific antibody against T congolense metacyclic VSG is being used to screen a
cDNA expression library prepared from metacyclic mRNA. Several gene sequences have
been identified which encode proteins and further experiments are in progress to confirm
whether these proteins—which may be VSGs—are specific to T congolense metacyclic forms.
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In collaboration with the Free University of Berlin (FR Germany), scientists are also analysing
the carbohydrate structures associated with T congolense metacyclic and bloodstream-form
VSGs (see Figure 10). This work focuses on the role of the VSG carbohydrate component in
the process of antigenic variation and possibly in blocking host recognition of trypanosome
VSG. Preliminary results indicate that VSG becomes more accessible to degradation by
digestive enzymes after removal of the carbohydrate component.
Previous studies suggested that VSG is attached to the surface of T b brucei bloodstream
forms by a lipid anchor. This lipid may be cleaved by a specific enzyme —phospholipase-C—
when the trypanosome sheds its surface coat, suggesting that pharmacological stimulation of
this enzyme might be exploited as a method for stimulating VSG cleavage and exposing
nonvariable surface molecules in bloodstream-form trypanosomes. Experiments conducted in
1987, in collaboration with the European Molecular Biology Laboratory in Heidelberg and the
Max-Planck Institute in Tübingen (FR Germany), showed that phospholipase C is present in
low concentration within the trypanosome cell. Research at ILRAD has shown that
bloodstream forms of T congolense have less phospholipase-C than T b brucei, while T vivax
has little or none. Detailed biochemical studies focusing on metacyclic forms of T congolense
indicate that other mechanisms may also be involved in conformational changes, and perhaps
release, of trypanosome VSG.
 T vivax surface antigens
Research on VSG composition and synthesis in T vivax has been limited because this species
tends to be more fragile than other trypanosomes and it is difficult to obtain T vivax parasites
in large numbers. Earlier work indicated that the VSG coat is less dense on T vivax than on T
b brucei or T congolense, suggesting that it may provide a less effective protective covering
than the VSG coats of the other species. VSG purified from a well characterized T vivax clone
originating from Nigeria is a relatively small glycoprotein of 46,000 daltons. In 1987, VSG was
partially purified from another T vivax clone, from Lugala in Uganda. Preliminary results
suggest that this is the smallest VSG so far described in any trypanosome. Antibodies raised
against VSGs from these two clones do not crossreact, indicating that they do not recognize a
crossreacting determinant on these parasites.
Because the T vivax surface coat is less dense that that of other species, other antigens might
be exposed on the surface which could trigger a protective immune response in infected
animals. Three nanvariable antigen molecules have been identified in bloodstream forms of
both T vivax clones which appear to be present on the cell surface and are also present on
uncoated procyclic trypanosomes. Two other antigens have been identified which occur
exclusively on the surface of procyclic forms. One of these two, with a molecular weight of
30,000 daltons, is of particular interest because it is capable of stimulating a strong antibody
response.
Scientists are also investigating factors which may have cell-killing functions when added to T
vivax parasites. One of these is aerolysin, a bacterial toxin which can make holes in
membranes. Aerolysin appears to kill T vivax parasites in vitro but not T congolense or T
brucei. Other laboratories have reported that sera from Cotton rats (Sigmodon hispidus)
contain an `antivivax' factor, but experiments conducted at ILRAD in 1987 failed to
substantiate this.
Recently, molecular biologists at ILRAD have shown that mRNA can be isolated from T vivax
and translated into proteins. Some of these gene products are recognized by the antisera
raised against T vivax variable and nonvariable surface antigens. The synthesis of these
proteins by recombinant DNA technology should make it possible to extend studies of T vivax
surface antigens despite the constraints posed by the fragility and limited availability of these
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parasites.
 Aspects of trypanosome metabolism
If trypanosome VSGs are too antigenically diverse to be used as material for a vaccine,
research on the cell biology of the parasites may reveal other sites which might be vulnerable
to antibody attack. One possible target could be the structures involved in endocytosis, the
process trypanosomes use to ingest biologically important molecules—such as essential
nutrients and growth and differentiation signals—from their environment. In trypanosomes,
endocytosis seems to occur through the specialized membrane of the flagellar pocket. It is
clear that various particulate and soluble substances enter the parasite at this site.
Bovine transferrin (a serum protein responsible for binding and transporting iron) can be
coupled with particles of colloidal gold which serve as markers, making it possible to visualize
by electron microscopy the organelles involved in endocytosis within the trypanosome. Work at
ILRAD has shown that transferrin/gold from the culture medium enters the fiagellar pocket and
is taken up by coated vesicles in the cell cytoplasm. VSG from the surface of the parasite is
endocytosed through the same process (Figure 11). The examination of trypanosomes in
serial section has revealed that the vesicles involved in endocytosis occur as complex
interconnected networks within the cell (Figures 12 and 13). Mathematical techniques have
also been introduced, in collaboration with the European Molecular Biology Laboratory, for
estimating the volume of these interconnected networks and of other compartments within the
parasite. Further work has shown that some parts of these endocytosis networks have
molecular sorting functions: T b brucei parasites are capable of separating VSG molecules
from transferrin/gold and also of separating the cross-reacting determinant from other parts of
the VSG molecule (Figure 14).
Figure 11. If trypanosomes are incubated in bovine transferrin coupled to colloidal gold, the
transferrin/gold is endocytosed and enters membrane-bound organelles inside the parasite. In
this electron micrograph the small gold particles (5nm) in the tubular network are endocytosed
transferrin/gold. The larger particles (15nm) are labeling the cross-reacting determinant of
trypanosome VSG. The cross-reacting determinant is found on the surface of the
trypanosome, in the flagellar pocket and in the same organelles as the transferrin/gold,
indicating that the two substances are internalized within the parasite in the same way
(magnification 64,800x).
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Figure 12. Section through a trypanosome incubated in bovine transferrin coupled with small
particles (5nm) of colloidal gold. Cross-reacting determinant from trypanosomal VSG was
labeled with larger (15nm) gold particles. The cross-reacting determinant is found on the
surface of the parasite, in the flagellar pocket and in many intracellular organelles, including
the Golgi apparatus and structures that also contain transferrin/gold (magnification 64,800x).
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Figure 13. Section through a trypanosome incubated in bovine transferrin coupled with small
particles (5nm) of colloidal gold. Cross-reacting determinant from trypanosomal VSG is
labeled with larger (15nm) gold particles. The transferrin/gold is found in a lysosome-like
structure and in cytoplasmic vesicles. The cross-reacting determinant is found on the surface
of the parasite, in the lysosome-like structure and in a tubular structure which connects with
the transferrin/goldcontaining vesicle, suggesting that the transferrin/gold is being excluded
from parts of the endocytosis pathway (magnification 127,575x).
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Figure 14. Sections through trypanosomes doubled labeled with antibodies directed against
the cross-reacting determinant and against another part of the VSG occasionally show tubular
structures that either label only with the cross-reacting determinant (labeled here with 15nm
particles of colloidal gold) or, as in this example, with the cross-reacting determinant and, at
one end only, with low levels of VSG (20nm gold particles). The VSG is associated mostly with
the trypanosome suface and the flagellar pocket, whereas the cross-reacting determinant is
found mostly within the cell (magnification 127,575x).
Experiments conducted in collaboration with the Chester Beatty Research Laboratories (UK)
have indicated that transferrin enters trypanosomes after recognition by a receptor molecule
on the surface of the parasite. The transferrin is carried into the cell where it releases iron in
an acidic compartment. The iron-free transferrin is then recycled to the cell surface where it is
released into the medium. Future work will concentrate on characterization of the organelles
involved in endocytosis and identification of the transferrin receptor on the surface of
trypanosomes.
Trypanosomes can be broken up under high pressure and cell fractions separated according
to size. Using this technique, ILRAD scientists have isolated membrane-bound structures from
bloodstream forms of T b brucei which contain a proteolytic (protein-splitting) enzyme probably
involved in the digestion of nutrients. This enzyme has been extensively purified and appears
as a single band of activity of approximately 27,000 daltons. The addition of serum from rats,
rabbits, cattle or humans to cell fractions containing this enzyme results in new bands of
enzymatic activity. The apparent molecular sizes of these bands of activity are different for
each mammalian species, suggesting that the host molecules which activate enzymatic
digestion in trypanosomes are species specific.
 Trypanosome cultivation in vitro
Culture systems are established which support the development of all three major African
trypanosome species throughout their life cycles. In vitro cultivation techniques are being
tested and improved on a life cycle stages for biochemical and continuous basis in order to
provide adequate numbers of trypanosomes at various life cycle stages for biochemical and
immunological research. Scientists also use trypanosomes produced in vitro to study the
action of trypanocidal drugs and to investigate drug resistance. In 1987, studies concentrated
on increasing the production of T b brucei metacyclic forms and improving techniques for
initiating cultures of T vivax.
T b brucei was the first trypanosome species to be maintained in culture, but it has proven
difficult to produce large numbers of metacyclic forms of this species and to distinguish T b
brucei metacyclics from bloodstream forms. A system to produce large numbers of T b brucei
metacyclic forms was introduced in 1986 and further developed in 1987, based on passaging
parasites alternately between in vitro culture and mice. Cultures were initiated with
bloodstream forms obtained from infected mice. These were maintained for 5 days in the
presence of bovine fibroblast cells and foetal bovine serum without changing the medium. On
the sixth day, the trypanosome population, containing epimastigotes, was transferred to a
feeder layer-free system and the medium was changed every 3 days. After a total of 14 days
in culture at 27°C, over 95% of the trypanosomes were infective for mice and parasites
separated from these populations on DE-52 columns appeared morphologically identical to
metacyclic forms observed in the saliva of infected tsetse. Using this system, it was possible
to produce nearly 300,000 metacyclic-type parasites from a single culture flask.
Three in vitro cultivation systems appear to stimulate the transformation of T b brucei
procyclics to epimastigote and metacyclic forms. These systems use embryonic cells from the
meadow vole Microtus montanus or cells from different insects as feeder cells, plus whole
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tissues or organs from tsetse or other flies. Work conducted at the University of
Massachusetts at Amherst (USA) and at ILRAD showed that T b brucei procyclics could be
cultured in the presence of a cell line from the Anopheles mosquito, the vector for malaria,
which is easily maintained in vitro. Procyclic forms previously maintained for periods of up to
96 days in liquid medium without feeder layer cells transformed into epimastigote and
metacyclic forms following the introduction of Anopheles cells into the cultures. Infective
trypanosomes, coated with VSG, were isolated from these cultures on DE-52 columns or by
agglutination of uncoated trypanosomes in bovine plasma. These could be used to initiate
cultures of bloodstream forms, thus completing the T b brucei cycle of development.
One stock of T congolense (C-49) isolated from the Trans Mara region of Kenya has proven to
be the most prolific of the ILRAD's T congolense stocks and clones for the production of
metaeyclic forms in vitro. Several new clones were derived from this stock in 1986 and one
was identified—IL3000—which appears to possess superior growth characteristics, both in
vitro and in experimental animals. Further experiments in 1987 showed that IL3000 is infective
for cattle, goats and mice and susceptible to the trypanocidal drug diminazene aceturate
(Berenil: Hoechst). Epimastigote forms of T congolense IL3000 were readily established in
culture and within 1 month were producing a high percentage of metacyclic trypanosomes.
Five months of production yielded 80 billion metacyclic forms, sufficient for a range of
biological, molecular biological and biochemical studies.
The unusual growth characteristics displayed by T congolense IL3000 may be due to
increased expression of genes involved in positive growth regulation. To identify any genomic
features peculiar to this clone, genomic DNA from IL3000 was compared with DNA from other
isolates of the C-49 stock as well as DNA from an unrelated T congolense clone, IL1180. A
repeated nucleotide sequence was identified in all the T congolense parasites examined
which has not been detected in T brucei (Figure 15). Copies of this sequence, arranged in
tandem arrays, occur in much higher numbers in IL3000 and other isolates from the C-49
stock than in T congolense IL1180. Further studies indicated that this sequence encodes the
35-nucleotide mini-exon repeat sequence found at one end of all trypanosomal cytoplasmic
messenger RNA.
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Figure 15. Relative abundance of the miniexon repeat in T congolense IL3000 (track 2)
compared with another T congolense clone, IL1180 (track 1), from a different serodeme. DNA
(1µ g) from each clone was digested with the restriction enzyme Hind III, separated on a 1 %
agarose gel and transferred to a nylon membrane. Hybridization was with a radiolabeled,
cloned Hind III fragment of 1,000 base pairs containing the repeat sequence.
Culture systems are available which support the development of several stocks of T vivax in
vitro throughout all phases of the parasite life cycle, including stocks which are restricted to
ruminants and the experimentally more amenable stocks which infect laboratory rodents. For
East African stocks of T vivax which only grow in cattle, it is possible to initiate low-
temperature cultures using infected tsetse proboscides or trypanosomes isolated from bovine
blood. All the vector stages of the parasite develop in these cultures, culminating in the
production of metacyclic trypanosomes which are infective for cattle.
 Host responses to trypanosome infection
 Early events in the skin
The development of a local skin reaction, or chancre, at the site of an infected tsetse bite is
the first host response to trypanosome infection. In domestic livestock, the largest and most
intensely inflamed chancre lesions often occur in animals that are most resistant to
trypanosome infection, suggesting that reactions in the chancre may contribute to host
resistance by limiting the rate of parasite growth during this first stage of infection in the skin.
Experiments conducted in collaboration with the University of Ibadan (Nigeria) showed that
some stocks of T congolense stimulate the development of chancres more readily than others.
When cattle or goats were infected with T congolense stocks which induced chancres and
then treated with trypanocidal drugs, they developed resistance to subsequent challenge with
the same parasite stocks. By contrast, infection with stocks which did not induce chancres
Trypanosomiasis
file:///C|/Users/dhmichael/Desktop/fulldoc_html/ilrad87/Trypanosomiasis.htm[5/19/2016 3:35:02 PM]
failed to confer resistance against homologous challenge.
When goats were infected with T congolense, nearly all the trypanosomes derived from the
resulting chancres up to 9 days after infection displayed VSGs characteristic of metacyclic
forms, even though the parasites resembled bloodstream forms. These findings suggest that
trypanosomes which display metacyclic VSGs may multiply in the chancre, allowing the host
to mount a comprehensive immune response to all the metacyclic variable antigen types
characteristic of a particular trypanosome stock.
In earlier experiments conducted in collaboration with the Kenya Goverenment's Veterinary
Research Laboratory, four buffalo and four susceptible Boran cattle were infected with T
congalense by tsetse. Skin reactions at the sites of infected tsetse bites were much less
severe in the buffalo than in the cattle and bloodstream parasites were detected much later in
the buffalo. To define more precisely the role of the skin reaction in the delayed appearance of
trypanosomes in the bloodstream, buffalo and cattle were infected in 1987 with the same T
congolense serodeme by intravenous injection directly into the bloodstream. Trypanosomes
were detected in the bloodstream sooner in both species than when infection had been by
tsetse transmission, but again bloodstream parasites appeared much later in the buffalo than
in the cattle. These results indicated that differences between the two species in control of
parasite numbers at the early stages of infection were not, or at least not entirely, due to
mechanisms in the skin.
 Parasite-host interaction in the bloodstream
Two responses are involved in host control of T b brucei infection in the bloodstream—control
of parasite growth by nonimmunological processes and destruction of parasites by host
antibodies. Detailed studies on both of these mechanisms have been in progress for several
years, concentrating on trypanoresistant and susceptible strains of mice. The goal is to identify
mechanisms which might be enhanced by chemotherapeutic or immunological means.
 Control of parasite growth
In vitro studies have confirmed previous observations that bloodstream forms of T b brucei
multiply in response to host-derived growth nutrients present in trace amounts in the sera of
infected animals. The growth rate of T b brucei bloodstream forms in a cell-free culture system
depended on the concentration of foetal bovine serum in the culture. Serum recovered from
cultures at peak trypanosome density had a reduced capacity to support further parasite
growth, suggesting that the trypanosomes had depleted the serum of nutrients. The serum
molecules which supported parasite growth were large but were otherwise extremely
heterogeneous, suggesting that growth promotion was associated with molecules of more
than one type.
In 1987, the cell-free culture system was improved, making it possible to maintain
trypanosomes in cell-free culture for long periods. Recent experiments have concentrated on
identifying the serum molecules required to support trypanosome growth. This work showed
that foetal bovine serum no longer supported trypanosome growth when lipoproteins were
removed. The re-introduction of either high- or low-density lipoprotein restored the serum's
growth-supporting capacity. Yet pure lipoprotein without serum did not support parasite
growth, nor did the addition of lipoprotein fully restore the growth-supporting capacity of foetal
bovine serum which had been depleted of growth nutrients. These results suggested that
lipoprotein may be one of several large molecules in foetal bovine serum which are required
for the multiplication of T b brucei in vitro. Further experiments are in progress to analyse the
role of high-and low-density lipoprotein in supporting trypanosome growth and to identify other
growth-supporting molecules.
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Non-immune responses to trypanosome infection were studied in previous years by treating
mice with dead Corynebacterium parvum, a bacterium which acts as a nonspecific
immunostimulator. C parvum treatment enhanced the ability to control T brucei infection, both
in intact mice and in mice whose immune system had been suppressed in different ways. In
studies conducted in 1987 using the cell-free culture system, macrophages derived from C
parvum-treated mice and macrophages which had been fed C parvum in vitro both released
molecules which inhibited multiplication of T brucei. The T brucei growth-inhibitors produced
by C parvum-stimulated macrophages could, in turn, be inhibited by increasing the
concentration of foetal bovine serum in the cultures. This suggested that the inhibitory
molecules might interact with growth-promoting molecules in foetal bovine serum or with a T
brucei receptor for the growth-promoting molecules. Present work concentrates on defining the
biochemical nature of the growth inhibitors and testing whether they compete with lipoprotein
or other molecules in foetal bovine serum.
 Host antibody production
In infected animals, antibodies directed against trypanosomal VSGs attach to the surface of
the parasites and mark them for destruction by macrophages or by the complement system.
Previous studies of T b brucei infection in mice suggested that host antibody responses do not
play a role in stimulating trypanosome transformation in the bloodstream, but only become
effective after most of the parasites have already switched to nondividing forms. In vitro
experiments were conducted in 1987 to examine the effects of anti-trypanosomal antibodies
on rapidly dividing forms of the parasite.
Both polyvalent and monoclonal antibodies raised against trypanosome VSG bound to the
surface of rapidly dividing bloodstream forms of T b brucei. While the parasites were exposed
to moderate levels of antibody they stopped multiplying but when the antibody was removed
they began multiplying again, indicating that they had not made an irreversible switch to
nondividing forms. The antibodies added to the cultures were rapidly destroyed; most likely,
they were endocytosed by the parasites. Work is now in progress to examine whether
trypanosomes in this system are in fact endocytosing anti-VSG antibody by the same
pathways identified for the uptake of transferrin/gold and VSG. The amount of antibody
required to halt trypanosome multiplication in vitro is also being compared with the amount
required to neutralize the parasites in an infected animal.
Mice which are highly susceptible to trypanosomiasis do not produce detectable antibodies
against the parasites, although their B lymphocytes are extensively activated and transformed
into plasma cells which contain antibody. In vitro analysis of spleen cells from infected
susceptible mice demonstrated that their activated B cells were defective in their capacity
both to synthesize and to secrete antibody. When resistant mice were infected with
trypanosomes, they produced antibodies which controlled the first parasitaemic wave, but
showed similar defective plasma cell function during the second parasitaemic wave. However,
in resistant mice antibody synthesis and secretion eventually recovered and parasitaemia was
controlled. At the time of parasite remission, vast amounts of antibody were synthesized and
secreted although the number of cells containing antibody did not increase.
In vitro studies conducted in 1987 indicated that loss of plasma cell function during
trypanosome infection was probably not due to the presence of suppressor host cell
populations, which could be detected by adoptive transfer, nor was the recovery of plasma cell
function due to the presence of contra-suppressor cells. Plasma cell function was restored in
vitro by incubation with T-cell growth factor preparations or the growth factor recombinant
human IL-2. Research is now in progress to analyse the signals required to induce antibody
synthesis and secretion by trypanosome-induced defective plasma cells. This work should
help clarify the mechanisms involved in the suppression and restoration of immune responses
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in infected animals.
In order to analyse immune responses to trypanosome infection in cattle, highly sensitive
techniques are required to measure the small quantities of antibody produced by bovine B
lymphocytes in vitro. A method was developed in 1987 using an inhibition enzyme-linked
immunosorbent assay (ELISA) with monoclonal antibodies raised against different types of
bovine immunoglobulin (Ig). Using monoclonal antibodies already available at ILRAD, it was
possible to calculate the total amounts of IgM and IgG present in bovine serum, lymph, nasal
secretions and white blood cells. Monoclonal antibodies are now being raised and tested
which recognize IgG1, IgG2 and IgA, as well as immunoglobulin light chains.
Detailed analysis of three monoclonal antibodies which all recognized bovine IgM revealed
that they detected three different epitopes on the IgM molecule. Only one recognized IgM on
B lymphocytes of all cattle tested. The proportion of lymphocytes expressing IgM varied widely
—from 4 to 31%—among different cattle, but remained the same over time for individual
animals and was very similar for identical twins. These findings suggested that the proportion
of B cells expressing IgM among the total B cell population may be genetically determined.
Work is now in progress to produce monoclonal antibodies which recognize B cells at different
stages of maturation. These will be used to study the activation of B-cell immunoglobulin
production during trypanosome infection.
Research is in progress on T vivax infection in goats to determine the type and level of
antibody response produced in animals infected with this species and the degree of protection
achieved against rechallenge with the same (homologous) parasites used in an initial infection.
In previous years, attempts to immunize goats by tsetse-transmitted infection followed by drug
treatment were not fully successful. Possibly the infected tsetse which transmitted the initial
infection extruded too few metacyclic parasites to induce an adequate immune response or to
represent the full repertoire of antigenic types which the animals encountered later on
rechallenge.
To overcome this problem, two groups of goats were infected with large numbers of
metacyclic trypanosomes, transmitted to one group by 100 infected tsetse feeding for 15 days
and to the other group by injection with 100 to 1 million metacyclic forms produced in vitro. All
goats were treated with diminazene aceturate 4 weeks after infection and rechallenged 3
weeks later. Only 8 out of 36 animals showed resistance to the challenge infection, though
infections were delayed and parasitaemias were lower than in controls. Sera from resistant
goats killed 50 to 60% of homologous metacyclic forms in vitro, while sera from the goats
which remained susceptible to challenge only killed 8 to 15%. Thus, induction of immunity was
erratic and appeared unrelated to the number of trypanosomes used in the original infection.
 Pathogenic effects of trypanosomiasis
 Anaemia
In most early cases of trypanosomiasis there is an acute onset of anaemia corresponding
closely with the detection of parasites in the bloodstream. Later, in chronic infections, levels of
anaemia are observed which appear unrelated to the rise and fall of parasite populations. A
project was initiated in 1987 to examine these two types of anaemia and to explore how some
breeds of cattle, such as the trypanotolerant N'Dama withstand the pathogenic effects of
trypanosome infection better than susceptible breeds.
Anaemia in trypanosome-infected animals may be due in art to impaired bone marrow
function. Undifferentiated stem cells in the bone marrow give rise to both erythrocytes (red
blood cells) and white blood cells of different types. Trypanosome infection in susceptible
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animals could have an inhibitory effect on cell production in the bone marrow and/or result in
the premature destruction of developing cells.
In order to investigate the effects of trypanosome infection on bone marrow function, a project
was initiated in 1987 to establish culture systems to support the growth of bovine bone
marrow cells in vitro. Both short- and long-term culture systems are being developed, as well
as improved methods for identifying cell types in bone marrow cultures. Bone marrow derived
from the sternum of calves was used to establish colonies which gave rise to erythrocytes
monocytes/macrophages, neutrophils. eosinophils and mast cells. Once these systems are
fully established, they will be used to compare bone marrow function in trypanosome-infected
and noninfected cattle.
Within the bone marrow, a network of stromal cells appears to influence the survival,
proliferation aid development of undifferentiated stem cells probably through the release of a
variety of soluble growth factors. In collaboration with Rockefeller University and
biotechnology organizations, ILRAD scientists are using DNA hybridization techniques to
produce bovine growth factors and investigate their rote in cell development in the bone
marrow.
 Endocrine dysfunction
In susceptible livestock growth, fertility and immune responses are all impaired during
trypanosome infection. These important functions are influenced by hormones—some of which
are small proteins secreted by glands of the endocrine system. Previous studies showed that
T b brucei parasites, perhaps when they were dying, released enzymes into the bloodstream
of infected mice which were capable of degrading host proteins. Research was initiated in
1987 to assess the effects of trypanosome infection on hormones in the bloodstream of
infected cattle and to elucidate the mechanisms involved. Scientists are measuring hormone
levels in Boran cattle infected with T congolense and comparing these with levels in
noninfected controls. An in vitro assay system is also being developed to measure the level of
parasite enzymes in the bloodstream of infected animals. This will be used to investigate
whether increased levels of parasite enzymes are associated with severity of disease.
 Control of infection in trypanotolerant and susceptible cattle
Studies in the field and more recently at ILRAD under experimental conditions have
established that N'Dama cattle are more capable of controlling trypanosome infection and
resisting clinical signs of disease than African Bos indicus cattle or the European taurine
breeds.
In a study initiated in 1985, eight N'Dama cattle and eight age- and sex-matched Boran were
challenged with tsetse-transmitted T congolense on five occasions. The first four T congolense
challenges were with clones belonging to four different serodemes of East African origin. The
fifth challenge was with the same clone used for the first challenge 2 years earlier. In addition
to the 16 cattle used throughout the experiment, groups of 8 naive Boran were included in the
second, third, fourth and fifth challenge.
Levels of parasitaemia, anaemia as indicated by packed red cell volume (PCV), red and white
blood cell counts and weight were measured throughout the series of experiments. Changes
in white blood cell populations and reproductive performance were also monitored during part
of the experimental period. At the end of each infection period, all the cattle were treated with
diminazene aceturate and an additional curative dose was given to any animal which
developed severe anaemia during infection, as demonstrated by a drop in PCV to 15% or
lower.
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 Control of parasitaemia and anaemia
None of the eight N'Dama required drug treatment during any of the five challenges. By
contrast, among the eight Boran challenged with four different serodemes, more than half
required treatment after each challenge. Four Boran required treatment after the second
challenge with the first serodeme, indicating that their resistance to trypanosome infection did
not improve significantly with repeated exposure. Altogether, the eight Boran required
treatment in 30 out of a total of 40 infection periods (75%). Half or more of the naive Boran
included in the second, third, fourth and fifth infection period also required treatment. These
experiments showed that the N'Dama were significantly more capable than the Boran of
withstanding the pathogenic effects of trypanosome infection, as indicated by levels of
anaemia, and also that all four serodemes of T congolense used in the experiment were of
similar virulence.
The responses of the two groups to the first and second challenge with the same T
congolense serodeme were considerably different, as shown in Figure 16. Parasitaemia levels
were slightly lower in the Boran following the second challenge, but the pattern was similar
during the two challenge periods. Only five of the eight N'Dama became parasitaemic during
the second challenge. These animals showed sporadic parasitaemia from 22 to 67 days after
challenge and thereafter no parasites were detected. During the first challenge, six out of eight
Boron required drug treatment; when challenged with the same serodeme 2 years later, four
out of eight still required early treatment. Their average PCVs dropped sharply in a similar
pattern during both challenge periods. Among the N'Dama, average PCVs dropped during the
first 35 days of the first challenge, though less steeply than among the Boron, reached a low
of 22.5%, and then gradually recovered. When the N'Damas were challenged a second time
with the same serodeme there was no appreciable drop in PCVs.
Figure 16. Development of parasitaemia and anaemia in N'Dama and Boran cattle during two
infections with the same T congolense serodeme (IL1180), in May 1985 and April 1987.
Trypanosomiasis
file:///C|/Users/dhmichael/Desktop/fulldoc_html/ilrad87/Trypanosomiasis.htm[5/19/2016 3:35:02 PM]
Groups of eight 13-month-old N'Dama and Boron were challenged successively with tsetse-
transmitted T congolense IL1180, IL2642, IL1587, IL2079 and again with IL1180. All the cattle
were treated with diminazene aceturate 4 to 6 months after each challenge. In addition, six of
the Boron required treatment during the first infection with IL1180 when their PCVs dropped to
15% and four required treatment during the second infection with IL1180. None of the N'Dama
required treatment. Graphs show levels of parasitaemia during the first (A) and second (B)
infections with IL1180, expressed as estimated average number of trypanosomes per ml of
blood, and levels of anaemia during the first (C) and second (D) infections, expressed as
average PCVs.
 Mechanisms of resistance
An analysis of sera collected during the first T congolense challenge period showed that levels
of antibody production were similar in the N'Dama and the Boron and antibodies produced by
both groups were capable of neutralizing trypanosomes in vitro with equal efficiency. However,
in the presence of antibodies, white blood cells from the N'Dama destroyed trypanosomes
more efficiently than white blood cells from the Boran. Such information on the mechanisms
involved in resistance to trypanosome infection could facilitate the search for genetic markers
to identify trypanotolerant animals for selective breeding programs.
 Epidemiology
 Trypanosome characterization
An important goal of ILRAD's trypanosomiasis research program is to develop accurate,
sensitive and simple methods to detect trypanosomes in infected tsetse and livestock and to
identify parasite species and serodemes. This work is important for trypanosomiasis diagnosis
and treatment and for epidemiological studies, for instance to assess levels of resistance to
trypanosome infection in livestock maintained in tsetse-infested areas, to evaluate the efficacy
of trypanocidal drug treatment programs or to predict the level of trypanosomiasis risk in an
area before introducing susceptible livestock.
 Serological typing
Monoclonal antibodies have been raised against in vitro-propagated procyclic forms of T
congolense, T vivax and T brucei (T b brucei and T b rhodesiense). In 1987, these reagents
were tested with procyclic and bloodstream forms of 13 T congolense, 6 T vivax, 4 T b
rhodesiense, 5 T b gambiense and 3 T simiae isolates from different parts of Africa, using IFA
and ELISA. The antibody raised against T brucei reacted specifically with the brucei group of
parasites, while the antibody against T congolense reacted with the T congolense and T
simiae isolates and the antibody against T vivax reacted only with parasites of that species.
Another monoclonal antibody raised against T congolense reacted specifically with T
congolense and not with T simiae.
These monoclonal antibodies have been used successfully to detect species-specific
trypanosomal antigens in sera from experimentally infected cattle. Arrangements are now
being made to test them for use in the field.
Experiments conducted in 1987 in collaboration with the Vrije Universiteit Brussel (Belgium)
indicated that the monoclonal antibody raised against T brucei can be used to diagnose T
evansi. This reagent recognized T evansi antigens in sera from goats experimentally infected
with isolates from South America and Indonesia and in sera from naturally infected water
buffalo and cattle from Indonesia. The T brucei monoclonal antibody also detected circulating
trypanosomal antigens in sera from human patients infected with T b rhodesiense. Out of 142
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patients known to be infected by parasitological diagnosis, the monoclonal antibody detected
trypanosomal antigens in 128 individuals, or 90.1%. The antibody also detected antigen in
sera from 8 out of 69 (11.6%) patients suspected of having trypanosomiasis but without a
positive parasitological diagnosis. When tested with sera from 425 non-infected individuals,
there were no false positive reactions. This test has been offered for further evaluation to the
WHO/UNDP/World Bank Special Program for Research and Training in Tropical Diseases.
Present work at ILRAD focuses on standardizing diagnostic assays for use in the field. The
monoclonal antibody raised against T brucei recognizes a protein epitope on trypanosomal
antigens, whereas the monoclonal antibodies against T congolense and T vivax recognize
carbohydrate epitopes. Efforts now concentrate on identifying a protein antigen for T
congolense and purifying the antigens recognized by ILRAD's monoclonal antibodies for each
species. The objective is to construct amino acid sequences and possibly to synthesize the
species-specific antigens for improved diagnostic tests.
Another project in 1987 concentrated on elucidating the antigenic composition of different
stocks of T vivax isolated at various locations in Africa. Preliminary results showed no
reactivity between parasites obtained from Nigeria and two different stocks from Kenya.
However, late infection sera from animals infected with a T vivax stock from Uganda
recognized a percentage of the Nigerian parasites. This confirms earlier evidence that
geographically separate populations of T vivax in Africa may possess overlapping antigenic
repertoires.
 Chromosome profiles
The development of improved methods for identifying trypanosome serodemes has
concentrated initially on T congolense stocks isolated from cattle at Kilifi in Kenya's Coast
Province. A technique known as molecular karyotyping makes it possible to compare the size
distribution of chromosomes from different groups of parasites.
Using this technique, it was possible to divide 117 T congolense clones, derived from 54
stocks isolated at Kilifi, into 18 chromosome-profile groups. Work in 1987 concentrated on
identifying any correlation between chromosome profiles and trypanosome serodemes. Seven
chromosome-profile groups were selected at random and a representative clone from each
group was inoculated into either a cow or a goat. The animals developed chronic infections or
became infected and recovered spontaneously. Sera obtained from each animal at monthly
intervals were then tested for cross-neutralizing antibody activity against other parasite clones
from the same chromosome profile group or from different groups.
Chronic infection sera from animals infected with one trypanosome clone neutralized most, if
not all, other clones from the same chromosome profile group, but not clones from different
groups. These results suggest that clones with the same chromosome profile may express
similar VSG repertoires and thus belong to the same serodeme.
 Use of DNA probes
ILRAD scientists have developed six species-specific DNA hybridization probes which
recognize T b brucei and T b gambiense, the T congolense parasites isolated at Kilifi,
savannah-type T congolense isolated elsewhere in East Africa, T simiae and East and West
African populations of T vivax. Work in this area has focused primarily on trypanosomes of the
Nannomonas subgenus—savannah-type T congolense, Kilifi-type T congolense and T simiae.
In 1987, a collaborative project was carried out with the University of Bristol (UK) to determine
whether either of ILRAD's T congolense probes could detect West African forest/riverine T
congolese isolated in The Gambia and whether ILRAD's East African T simiae probe could
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detect West African T simiae.
ILRAD's T simiae probe hybridized to the T simiae sample from West Africa, but the
savannah-type T congolense probe hybridized only very weakly to the riverine/forest T
congolense and the Kilifi-type T congolense probe did not hybridize to this sample at all
(Figure 17). Re-examination of the riverine/forest isolates revealed that they comprised mixed
populations including both savannah-type and forest-type parasites. A DNA probe for forest-
type T congolense was subsequently cloned at Bristol which did not hybridize with savannah-
type T congolense or with T congolense from Kilifi.
Figure 17. Dot blots were made on filter paper using DNA from six different trypanosome
isolates known or suspected to be T congolense or T simiae. T b brucei material was used as
a control. Each sample was spotted several times across the filter and the filter was cut into
three strips, each containing two spots from each isolate. The strips were hybridized
separately with DNA probes specific for East African savannah-type T congolense (A), Kilifi-
type T congolense (B) or T simiae (C). Spots at positions 1, 2, 3 and 5 contained DNA from
West African T congolense, which hybridized weakly with the savannah-type probe but not
with the others. Subsequent analysis revealed that these isolates contained mixed populations
of riverine/forest and savannah-type parasites. Spots at position 4 contained DNA from T
congolense isolated at Kilifi which hybridized exclusively with the Kilifi-type probe, and spots at
position 6 contained DNA from West African T simiae which hybridized exclusively with the
East African T simiae probe. The arrow indicates the position of T brucei DNA.
This work led to the following conclusions: (1) ILRAD's T simiae DNA probe detects both West
and East African T simiae; (2) ILRAD's T congolense probe detects savannah-type T
congolense from both East and West Africa but not West African riverine/forest or Kilifi-type T
congolense; and (3) West African riverine/ forest T congolense may comprise a genomically
distinct group. Several other laboratories have expressed interest in ILRAD's trypanosome
DNA probes and more collaborative experiments will be conducted in this area. One objective
is to test ILRAD's probes with a larger number and greater diversity of trypanosomes isolated
in different parts of Africa.
 Identification of species-specific proteins
In 1987, scientists investigated glycoproteins on the surface of procyclic forms of different
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trypanosome species. Species specific differences in procyclic surface proteins might be used
to identify trypanosome species which are difficult to distinguish by other methods.
Glycoproteins were identified on the surface of T congolense, Kilifi-type T congolense, T
simiae, T b gambiense, T b rhodesiense and T b brucei procyclic forms. Using several
labeling methods, it was possible to distinguish Kilifi-type T congolense, T simiae and T b
gambiense from the other species. This project was carried out in collaboration with the
University of Nairobi.
 Livestock production under trypanosomiasis risk
In the vast tsetse-infested regions of Africa, livestock production depends largely on
trypanocidal drugs, both to prevent trypanosome infection and to treat infected animals.
Regular drug treatment will continue to be the most important measure for trypanosomiasis
control until the problems associated with initiating and maintaining tsetse control are
overcome or an effective trypanosomiasis vaccine becomes available. However, no new
trypanocidal compound has been introduced commercially for almost 30 years. At the same
time, there have been increasing reports from the field of trypanosome resistance to some of
the most widely used trypanocides, including isometamidium chloride (Samorin: May and
Baker), most often used to prevent trypanosome infection in livestock, and diminazene
aceturate, generally used to cure infection.
 Trypanocidal drugs: detection and testing in vitro
One major constraint on the development of new trypanocidal drugs for human and veterinary
use is the expense of drug testing in experimental animals. In vitro systems are urgently
needed to assess drug resistance in trypanosome populations and to test the effectiveness of
new trypanocidal compounds. Although the activity of a trypanocidal compound in the
laboratory may not always correspond precisely with its effectiveness in the field, in vitro drug
testing can provide important insights into problems associated with trypanosomiasis control
and possibilities for improvement.
Initial research in this area was conducted to determine whether in vitro cultivation might alter
the drug sensitivity or resistance of trypanosome populations. In collaboration with the Kenya
Trypanosomiasis Research Institute and the Free University of Berlin, ILRAD scientists
maintained a stock of T b brucei in vitro which was known to be sensitive to one commercial
trypanocide and resistant to four others. Parasites maintained for 4 months as bloodstream
forms or propagated through different stages of the life cycle all retained their initial range and
level of drug sensitivity or resistance.
Two simple, inexpensive methods for assessing drug resistance are now being tested. The
first is a drug incubation infectivity test. Bloodstream-form trypanosomes are isolated from an
infected animal and cultured in vitro with various concentrations of a trypanocidal drug. After a
period of incubation, some of the parasites are injected into mice while the remainder are
assessed for their ability to multiply in vitro in the presence of the drug. Drug-resistant
trypanosomes continue multiplying in vitro and retain their infectivity for mice, while drug-
sensitive parasites do not. This method has been tested successfully with stocks of T b brucei
and T congolense; it cannot be used with most stocks of T vivax since this species is
generally not infective for mice.
The second method involves isolating bloodstream-form trypanosomes from an infected
animal and allowing the parasites to develop into uncoated procyclic forms in vitro. Different
concentrations of trypanocidal drug are incubated with the cultures and parasite growth is
assessed using a Coulter counter. This approach may be more suitable for small laboratories
in the field because procyclic trypanosomes are easier to maintain in culture than bloodstream
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forms: no feeder-layer cells or incubator is required. Preliminary experiments showed that both
diminazene aceturate and isometamidium chloride inhibited the multiplication of T b brucei and
T congolense procyclic forms, and clear distinctions could be observed between drug-resistant
and sensitive parasite strains. This approach has the advantage of simplicity, but again it is
not suitable for use with T vivax because the procyclic forms of this species do not multiply in
vitro, even in the absence of trypanocidal drugs.
Scientists are also using in vitro assay systems to assess the trypanocidal activity of several
new drugs. One of these, 9-deazainosine, may be useful for treating trypanosome infections
which are resistant to currently available compounds. In in vitro tests, 9-deazainosine had a
trypanocidal effect on a T brucei stock which was resistant to both diminazene aceturate and
isometamidium chloride. This drug is now being tested using other drug-resistant trypanosome
stocks.
 Trypanocidal drugs: detection in treated animals
To evaluate the effectiveness of trypanocidal drug treatment and devise more effective
treatment regimes, techniques are required to assess the level of trypanocidal activity present
in the bloodstream of treated animals. Several methods have been developed and tested to
measure the amount of trypanocidal drugs present in mammalian sera. Different techniques
for extraction and measurement are required for each different compound. ILRAD scientists
began work in 1987 on a new approach using a bioassay to measure the inhibition of parasite
growth and infectivity as an indication of trypanocidal activity in serum samples from treated
animals.
First, T b brucei bloodstream forms were maintained for 6 months in an in vitro culture system
which supported a daily growth rate of approximately 500%. Parasites from this population
were then incubated with sera taken from goats after treatment with diminazene aceturate.
Sera from treated goats inhibited both trypanosome growth and infectivity, with infectivity the
more sensitive indicator of drug activity. A difference in the inhibition of infectivity could be
observed between drug-resistant and susceptible parasite strains. Further studies involve
culturing trypanosomes with sera taken from cattle at different times after drug treatment in
order to estimate the period of effective protection. One drawback is that serum from some
animals has a trypanocidal effect even in the absence of drugs.
Very few trypanocidal drugs can pass through the natural physiological barriers that separate
the central nervous system from the bloodstream. For this reason, drug treatment becomes
much more difficult in cases where trypanosomes enter the central nervous system. In a
project supported by WHO, ILRAD scientists have developed a cannulation system, using
goats, to monitor drug levels in cerebrospinal fluid. The bioassay which has been developed
to measure trypanocidal activity in sera from treated animals will now be tested using
cerebrospinal fluid.
 Trypanocidal drugs: evaluation of protection
Livestock owners in Africa have been using isometamidium chloride for over 25 years to
prevent trypanosome infections in cattle. Despite the widespread use of this and other
trypanocidal drugs, very little is known about the effectiveness or duration of protection
afforded by drug treatment. Reports from the field have indicated that the period of protection
provided by isometamidium chloride can vary considerably from one area to another. ILRAD
scientists are investigating this variation in drug protection in collaboration with the University
of Glasgow (UK).
Although earlier studies had shown that cattle treated with isometamidium chloride (0.5 mg/kg)
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were protected for at least 3 months against monthly tsetse-transmitted challenge with certain
stocks of T congolense, drug treatment conferred protection against a Nigerian population of T
vivax for only 2 months and protection against a T vivax population isolated in Kilifi, Kenya,
lasted less than 4 weeks. However, the same drug was fully effective as a curative against
pre-existing infections with either parasite population.
In 1987, similar experiments were conducted using two other Kenyan T vivax populations, one
originating from Galana and one from Likoni (Figure 18). Cattle treated with isometamidium
chloride (0.5 mg/kg) became infected with the Galana parasite population 1 month after drug
treatment and with the Likoni parasites 2 months after treatment. As in the previous
experiments, both parasite populations were fully sensitive to the therapeutic activity of
isometamidium chloride (at 0.5 mg/kg) yet resistant to the drug's prophylactic activity.
T vivax 
strain
Animal 
number
—Infection Detected—
Month Day After Monthly Challenge
IL2969
(Kilifi)
 
A1 2 7
A2 2 9
A3 1 12
A4 1 23
A5 1 24
IL2982
(Galana)
 
B1 1 9
B2 1 9
B3 1 9
B4 1 14
B5 1 9
IL2986
(Likoni)
 
C1 2 12
C2 2 12
C3 2 12
C4 2 12
C5 2 14
Figure 18. Effectiveness of isometamidium chloride for preventing T vivax infection in cattle:
results from two experiments using parasites isolated in Kenya. Three groups of five yearling
Boran steers were inoculated with isometamidium chloride (0.5 mg/kg) and then challenged
with one of three different stocks of T vivax derived from different locations in Kenya's Coast
Province. All animals were challenged monthly with 10 infected tsetse, beginning 1 month
after drug treatment. Two untreated controls were also challenged monthly with each stock as
a check on the infectivity of the parasites.
These results are interesting because isometamidium chloride is used primarily as a
prophylactic drug. They indicate that tests using isometamidium chloride to treat pre-existing
infection do not provide a reliable indication of the effectiveness of the drug as a prophylactic
to prevent infection.
 African trypanotolerant livestock network
Small populations of cattle, sheep and goats are found in West and Central Africa which
possess some degree of resistance to trypanosomiasis. This resistance, which has been
termed trypanotolerance, is generally attributed to the N'Dama and West African Shorthorn
breeds of cattle, Djallonké sheep and Dwarf West African goats. Field studies have shown that
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trypanotolerant cattle can be as productive as other indigenous African breeds in areas of zero
or low trypanosomiasis risk; in areas of high risk, only trypanotolerant breeds can survive.
Trypanotolerant N'Dama cattle originating in the Fouta Djallon region of Guinea have been
established in several tsetse-infested areas of Central Africa—in the Central African Republic,
Gabon, Congo and Zaire. N'Dama cattle are now being imported by several other countries in
West and Central Africa where they are forming the nucleus of livestock development
programs in tsetse-infested areas.
ILRAD is collaborating with ILCA and with national livestock ministries and development
programs in West and Central Africa in a research network established to study the health and
productivity of trypanotolerant and susceptible cattle, sheep and goats under different
management conditions and exposed to different levels of tsetse-transmitted trypanosomiasis
risk. The goal of this African Trypanotolerant Livestock Network is to provide information on
genetic and acquired aspects of trypanotolerance and the factors affecting the susceptibility of
livestock to trypanosome infection. This information should lead to improved breeding
programs and the optimum use of trypanotolerant livestock in the vast tsetse-infested regions
of Africa. The research network will also provide a framework for testing existing and future
trypanosomiasis control measures as they become available.
Scientists from national programs are collecting information on animal health, animal
production and tsetse challenge at 15 sites in West and Central Africa—5 in The Gambia, 4 in
Zaire, 2 in Togo, 2 in Ivory Coast, 1 in Gabon and 1 in Senegal. Comparable information is
also being collected at three associated sites in East Africa—in Kenya, Tanzania and Ethiopia.
ILRAD provides training and supervision for monitoring tsetse populations, trypanosome
infection rates in tsetse and livestock and the health status of animals included in the study.
ILCA helps collect information on animal production and nutrition and is responsible for
processing and analysing health and productivity data from all the network sites. By the end of
1987, participants in the network were collecting data every month on over 10,000 animals.
Because of the crucial importance of accurate data collection and standardization among the
different sites, field staff working within the network receive intensive training and careful
supervision. Two 7-week training courses are conducted at ILRAD every year, in English and
in French. By the end of 1987, 63 staff members working in the network had received training
at ILRAD.
 Tsetse challenge and trypanosome infection
The tsetse component of the African Trypanotolerant Livestock Network involves collecting
data at 12 sites on a monthly basis. Tsetse density is measured for 5 to 10 consecutive days
each month, using biconical traps. Relative density, expressed as the average number of flies
captured per trap each day, is a function of real tsetse density, behaviour and nutritional
status plus position of the traps and weather conditions. Analyses completed in 1987 revealed
a statistically significant relationship between monthly estimates of tsetse challenge and
trypanosome prevalence in trypanotolerant cattle—both across sites and, in Ivory Coast and
Zaire, between locations at individual sites.
Intensive research has been initiated at several sites aimed at developing more accurate
methods for estimating tsetse challenge. This work includes tsetse mark/release/recapture
experiments to improve estimates of actual population density and experiments to determine
the nutritional status of tsetse populations by fat/haematin analysis. Network scientists are
also sending samples of tsetse flies and mammalian blood to ILRAD for analysis to detect
trypanosome infection and determine parasite species.
 Evaluation of trypanosomiasis control
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In association with the African Trypanotolerant Livestock Network, the Kenya Ministry of
Livestock Development initiated a project in 1982 at Muhaka near the Kenya coast. The goal
was to monitor the health and productivity of susceptible East African Zebu cattle maintained
under village conditions in a tsetse-infested area with and without regular prophylactic drug
treatment. The area was infested with Glossina pallidipes, G brevipalpis and G austeni. T
congolense and T vivax infections were detected in cattle, with monthly infection rates
averaging from 1 to 8%.
Two-thirds of the cattle included in the study were treated on a regular basis with
isometamidium chloride, while the others, acting as controls, received only occasional curative
treatment. Results reported in 1987 showed that cattle receiving regular drug treatment were
20% more productive than controls (Figure 19).
Production 
Parameter
With 
Treatment
Without 
Treatment
Viability
     Annual cow viability (%) 95.0 95.0
     Calf viability to 12 months (%) 96.3 91.3
     Young stock viability 12-30 months (%) 98.9 97.5
Body weights
     Cow weight (kg) 185.0 189.0
     Calf weight at 12 months (kg) 63.4 58.5
Productivity
     Annual calving rate (%) 77.0 76.4
     Annual extracted milk yield (kg) 150.6 120.5
Annual productivity index: weight of
12-month-old calf plus liveweight equivalent 
of milk extracted
     Productivity per cow (kg) 56.4 47.6
     Productivity per 100 kg body weight 
of cow (kg)
30.5 25.2
     Productivity per 100 kg 124.8 103.8
liveweight of cow (kg)
Figure 19. Effect of regular prophylactic treatment with isometamidium chloride on the
productivity of East African Zebu cattle in Muhaka, Kenya.
A tsetse control campaign was initiated in 1987 at a network site in the Boundiali area of Ivory
Coast using insecticide-impregnated traps and screens. Estimates of tsetse challenge and
trypanosome prevalence in livestock in the experimental area and in a control area will allow a
thorough evaluation of the effectiveness of this type of tsetse control operation.
 Indications of heritability
If genetic improvement of trypanotolerant livestock is to be achieved, it is vital to determine
whether the components of trypanotolerance are under genetic control. Trypanotolerance
appears to be associated with at least three possibly related but genetically independent
characteristics—the ability to control parasitaemia, to resist anaemia and to develop an
effective immune response. Breeding programs have been introduced at network sites with
high natural tsetse challenge in Gabon and Zaire to build up groups of paternal half-siblings
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which will make it possible to estimate the heritability of these traits. Preliminary results
suggest that the ability to maintain PCV levels under high natural challenge might provide the
basis for a practical selection approach for anaemia control. In certain circumstances it may
also be possible to select for the ability to acquire resistance after repeated infection.
An association between disease resistance and MHC type has been demonstrated in some
domestic and laboratory animals. The development of a practicable and reliable system for
typing large numbers of cattle according to class I MHC antigens—and selected individuals
according to class II antigens—has made it possible to begin searching for associations
between MHC type and trypanotolerance. Network scientists have collected blood samples
from approximately 800 N'Dama cattle in The Gambia and Zaire and 200 of these have been
typed using ILRAD's panel of antisera and monoclonal antibodies. An association between
MHC type and trypanotolerance would make it possible to develop highly cost-effective
programs to select trypanotolerant animals. Preliminary examination of class I antigens has
indicated that the N'Dama have a number of characteristics seen in no other breed so far
examined. These differences will be analysed in detail once MHC typing of all the animals is
complete.
 Research on N'Dama productivity in The Gambia and Senegal
ILCA and ILRAD are participating in a research project on the productivity of N'Dama cattle at
five village sites in The Gambia and Senegal. The project was initiated in 1985 under the
African Trypanotolerant Livestock Network with funding from the European Economic
Community (EEC). The objective is to evaluate the productivity of N'Dama cattle exposed to
different levels of tsetse challenge and trypanosomiasis risk under traditional village
management conditions. Information collected through this project will allow a critical
evaluation of the degree of trypanotolerance exhibited by N'Dama, the possible role of
acquired resistance and the influence of various management factors. The research team
works in close collaboration with a tsetse research project funded by the British Government's
Overseas Development Administration (ODA) and with a large-scale livestock development
project funded by the African Development Bank. All three projects are based at the
International Trypanotolerance Centre at Kerr Serigne in The Gambia.
Study sites in The Gambia (Figure 20) are located at Gunjur and Pirang villages near the
coast, with low trypanosomiasis challenge transmitted by G palpalis gambiensis; at Keneba
and Nioro Jattaba villages about 150 km inland in an area moderately infested by G morsitans
submorsitans; and further inland at Bansang, where both tsetse species are present and
trypanosomiasis challenge appears to be higher. Information has been collected on a regular
basis since January 1986 covering 1200 cattle in Gunjur and Keneba. In June 1986, the study
was extended to cover an additional 700 cattle in Pirang and Nioro Jattaba. In 1987, the
project was extended to Bansang in The Gambia and to Kolda in southern Senegal in
collaboration with the Centre de Recherches Zootechniques.
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Figure 20. Map of The Gambia and southern Senegal showing the location of six research
sites included in the African Trypanonotolerant Livestock Network and the headquarters of the
International Trypanotolerance Centre (ITC).
The ILCA/ILRAD team is investigating the health and productivity of N'Dama cattle at the study
sites by monitoring trypanosome prevalence, anaemia as indicated by PCV levels and
productivity as indicated by calving rates, viability, weight changes and milk production.
Information is also being gathered on the presence of anti-trypanosomal antibodies and the
incidence of other infectious diseases, and N'Dama herds at Kerr Serigne and Keneba are
being typed in terms of class I MHC. The ODA-funded team collects data on tsetse
distribution, density and trypanosome infection rates and on the movement of livestock in
relationship to the location of tsetse at different times of year.
Blood samples are taken from all cattle included in the study on a monthly basis and
trypanosomiasis prevalence is assessed as the percentage of animals with detectable
infections. Figure 21 shows monthly trypanosomiasis prevalence at four sites from June 1986
through May 1987, revealing a pattern of higher infection rates during the rainy season. T
congolense was encountered more frequently than T vivax at all four sites, while no T brucei
infection was observed. Analysis of data collected at two sites (Keneba and Gunjur) over a 17-
month period showed that higher trypanosomiasis prevalence was associated with higher
tsetse infestation rates, higher anti-trypanosomal antibody levels, lower PCV levels and lower
average body weights.
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Figure 21. Monthly trypanosomiasis prevalence in N'Dama cattle at four study sites in The
Gambia from June 1986 ;o May 1987.
Trypanosomiasis prevalence differed widely between age groups, with young adult cattle most
frequently infected. Trypanosomiasis prevalence was higher and average PCV values were
lower for male than for female cattle, perhaps reflecting greater stress among male animals
used for traction. Tests for anti-trypanosomal antibodies revealed maternal antibodies in
calves up to 3 months of age.
A comparison of average monthly body weights from June 1986 through May 1987 revealed a
dramatic weight loss at all four sites during the latter part of the dry season, probably related to
nutritional factors. Calf growth and daily milk offtake increased during the rains and dropped
during the dry season. Milk offtake for an average 10-month lactation period was 300 kg in
Gunjur and 333 kg in Keneba.
The age at first calving was 4 to 5 years and the average calving interval was 23 months. This
late age at first calving and prolonged calving interval prompted an investigation of the length
and frequency of normal oestrus cycles in N'Dama cows. However, it has proven difficult to
detect oestrus in animals kept under traditional husbandry conditions.
Scientists are testing the effects of dry-season supplementary feeding on calving rates and
calf growth. The provision of groundnut meal to young calves at Keneba 3 times a week
increased liveweight gains by an average of 49% during the 1987 dry season. During the
same 6-month period at Nioro Jattaba, milk offtake, calf growth and cow body weight
improved among cows supplemented with groundnut meal.
By the end of 1987, data collection was well established at all five sites in The Gambia and at
Kolda in Senegal. The collection of large data sets on the same animals every month should
make it possible to calculate productivity indices for the different sites and to design a model
to predict the influence of various factors on production values. Strategic interventions will also
be tested in the areas of animal health, nutrition and management.
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Epidemiology and Socio-economics
A research program on the epidemiology and socio-economics of animal disease and its
control in Africa was initiated in late 1987 with funding provided by the Rockefeller Foundation.
The objectives are to identify the factors which govern the successful application of improved
disease control measures—particularly the widespread use of immunization—and to assess
the likely impact of improved disease control in economic, social and environmental terms.
The impact of disease control measures will be considered at the regional, national and farm
level. The project will focus initially on the control of theileriosis within the general framework
of tick-borne disease control.
In the initial stages, a major aspect of this program will be research into methods of assessing
the incidence of tick-borne diseases and their impact on productiviy. Work will also focus on
the epidemiological and socio-economic consequences of intervention strategies, such as
immunization, chemotherapy and strategic tick control. The methodologies developed through
this program should eventually be of value for assessing the impact of control options for other
diseases in livestock. Much of this research will be carried out in close collaboration with
livestock ministries and research organizations in the countries affected by theileriosis and
with other international and regional institutions having similar objectives. ILRAD has agreed
on a memorandum of understanding with the Kenya Agricultural Research Institute for
collaborative research in this area.
The program at ILRAD will include:
the compilation of extensive data bases on livestock production in the countries most
severely affected by theileriosis
the characterization and zonation of livestock production systems based on disease
epidemiology, management system, agro-ecological zone and socio-economic
environment with a view to determining the impact of potential disease control options
under a variety of circumstances
the development and verification of predictive models which can be used to ensure the
optimal application of improved disease control measures for specific locations or
production systems
the development and testing of protocols for disease-control impact studies at the farm
and community level.
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 Training
ILRAD's training program is designed primarily to develop veterinary research and disease
control capabilities in African countries where trypanosomiasis and ECF are important animal
health problems. The development of scientific and technical resources in these countries
receives high priority at ILRAD: in 1987, training activities accounted for nearly 10% of the
annual budget.
These funds support individualized training programs for scientists and technicians from
laboratories and field programs in Africa and other developing areas, postgraduate training for
students working towards master's and doctoral degrees and post-doctoral positions to
enhance the professional knowledge and experience of young scientists from many parts of
the world. In addition to training for individuals, courses, conferences and workshops are held
throughout the year on topics directly related to ILRAD's research program.
In 1987, 13 scientists and technicians came to ILRAD for specialized technical training for
periods lasting from 1 week to 7 months (Figure 22). Their training programs were planned on
an individual basis according to the needs of their home institutions. All were staff members of
national research laboratories or livestock development programs in developing countries. In
addition, ILRAD sponsored three scientists—from Malawi, Kenya and Zaire—who attended a
2-week training seminar on African trypanosomiasis in Togo organized by the OAU, FAO and
WHO.
Country 1986 1987 Country 1986 1987
Specialized technical training
Burundi 2 1 Somalia 2 –
Central African
Republic
1 – Tanzania 2 1
Ethiopia 2 – Uganda – 2
India – 1 Zimbabwe 2 –
Kenya 5 7 Italy 2 –
Nigeria 1 1 USA 1 –
Rwanda 2 –  
Post-graduate training
Ethiopia – 1 Zaire 1 1
Ghana 1 1 Canada – 1
Kenya 8 9 Italy 2 2 2
Nigeria 2 1 Netherlands 1 1
Sudan 1 1 UK 1 2
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Uganda 1 1 USA – 1
Post-doctoral training
Kenya 3 3 Germany(FR) 1 2
Tanzania – 1 Ireland 1 2
Australia 1 1 UK 2 2
France 1 1 USA 4 2
Figure 22. Individual training at ILRAD in 1986 and 1987: number of participants in different
types of training by country of origin. Post-graduate training includes both Research Fellows
and Visiting Research Fellows. Post-doctoral training includes both Senior Research Fellows
and Post-Doctoral Fellows.
Fifteen post-graduate students were working at ILRAD in 1987 on Research Fellowships
lasting from 1 to 4 years (Figure 22). The 12 Research Fellows from African countries were all
supported by ILRAD; two also received support from the Kenya Government and one from
WHO. Three Research Fellows from developed countries were supported by their home
governments. All these students worked with ILRAD scientists on projects closely related to
the research program. Three Research Fellows received their Ph.D. degrees and one
received an M.Sc. degree in 1987, based on research carried out at ILRAD, and one Kenyan
staff member from the ILRAD/Veterinary Research Laboratory Wildlife Project received his
M.Sc. degree in the USA. Seven Visiting Research Fellows also worked at ILRAD for shorter
periods during the year.
Two Senior Research Fellows worked at ILRAD during 1987, one from Kenya and one from
Tanzania. This program is for young scientists working at universities or research institutes,
principally in Africa, who come to ILRAD for several months to enhance their research
experience.
Post-Doctoral Fellows are selected on an international basis to meet specific requirements of
the research program. They normally work at ILRAD for 2 years. Twelve Post-Doctoral
Fellows worked at ILRAD in 1987—from Kenya, Ireland, Germany (FR), the UK, the USA,
Australia and France.
In addition to training activities organized on an individual basis, four training courses were
held in 1987, with a total of 44 participants from 24 African countries. The first, from January to
March, was a joint course on African animal trypanosomiasis and the development of regions
affected by the disease, conducted by ILRAD, FAO and the Centre de Recherche sur les
Trypanosomiases animales in Burkina Faso. The course was conducted in French and held in
Bobo Dioulasso. Three courses were conducted at ILRAD during the year, one in English on
the diagnosis of haemoprotozoan diseases, with emphasis on trypanosomiasis, and two in
French on trypanosomiasis and other parasitic diseases, intended primarily for staff members
working in the African Trypanotolerant Livestock Network.
ILRAD held a major international workshop in September on ruminant class II MHC genes and
gene products and their association with disease susceptibility and resistance. Participants in
the 4-day meeting included 24 specialists from 9 different countries, 6 participants from the
University of Nairobi and research institutes in Kenya and several ILRAD staff members. The
proceedings are being published as a special issue of Animal Genetics. In November, ILRAD
hosted an international meeting of the African Trypanotolerant Livestock Network.
Researchers working at Network sites in nine African countries presented results from the past
2 years, evaluated future research plans and heard scientific reviews from invited specialists.
 Information services
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The primary responsibility of ILRAD's Information Services Department is publication of the
annual report and the quarterly newsletter, ILRAD Reports, in English and French. In 1987,
major articles in ILRAD Reports reviewed research on drug treatment for the prevention and
cure of trypanosomiasis, collaborative programs with national and regional institutions in
Kenya and other African countries, studies on the bovine MHC and work on Theileria strain
characterization. The newsletter also described conferences and workshops held at ILRAD
and listed articles and other publications by ILRAD staff.
For the first time at the beginning of 1987, an annual highlights report was published in
English and French, giving a brief description of research and training activities in 1986. The
annual report, quarterly newsletter and annual highlights are intended for a wide range of
readers, with emphasis on laboratory and field workers in Africa who are responsible for
animal health. The Information Services Department also issues a weekly Internal Newsletter
in English and Kiswahili. This is distributed to staff members and the Board of Directors.
Detailed results from ILRAD's research program are published in international journals and
scholarly books in a form suitable for a specialized scientific audience. In 1987, ILRAD staff
members published 64 journal articles plus 7 chapters and 1 full-length report. These are
listed in a separate section of this annual report.
In September 1987, ILRAD participated for the fourth time in the Nairobi International Show,
which is sponsored every year by the Agricultural Society of Kenya. ILRAD's exhibit included a
poster display and presentation of video productions on ILRAD in English and Kiswahili.
Information Services produced-a short brochure—ILRAD: questions and answers—in both
languages for distribution during the Show and for visitors to ILRAD. An updated brochure,
Welcome to ILRAD, was also produced in 1987 with information about travel, health,
accommodation and other areas of concern for visitors from abroad.
Considerable effort is devoted to maintaining and verifying ILRAD's distribution list and
responding to requests for publications from around the world. The mailing list gradually
expanded in 1987 as scientists, government officials, librarians, journalists and others wrote in
asking to receive ILRAD publications on a regular basis (Figure 23).
Region
Countries Institutions/Individuals
1986 1987 1986 1987
Anglophone Africa 25 24 745 883
Francophone Africa 23 23 268 316
Anglophone and other Europe 19 19 235 254
Francophone Europe 2 2 41 47
North and South America 25 26 277 286
Near and Far East 31 3 233 274
Total 125 125 1799 2060
Figure 23. Comparison of ILRAD Reports distribution at the end of 1987 and the end of 1986.
In addition to keeping journalists informed about scientific progress at ILRAD, the Information
Services Department contacts local newspaper reporters when important visitors come to
IL,RAD or meetings take place which would be of interest to the general public. Information
Services also distributes press releases and photographs on these occasions. The three daily
newspapers in Nairobi published 21 articles in 1987 giving favourable coverage to activities at
ILRAD.
 The ILRAD library
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The ILRAD library serves staff members, visiting scientists, participants in the training program
and staff of other research institutes, government departments and universities in Kenya. The
specialized collection concentrates on topics related to ILRAD's research program, with
emphasis on scientific journals. Subscriptions to 228 international journals and 36 monograph
series cover such fields as parasitology, immunology, biochemistry, entomology, cell biology
and veterinary medicine, including several indexing and abstracting journals. Journal
subscriptions are reviewed every year according to the recommendations of the scientific staff.
The collection of scientific reference books is reviewed on a continuous basis. In 1987, the
library acquired 230 new books, including several titles requested by the new Epidemiology
and Socio-economics Unit. With irrelevant and out-dated material removed, the book collection
has been trimmed to about 2,500 volumes.
The ILRAD library participates in an interlibrary loan network along with the University of
Nairobi, the Kenya Government's Veterinary Research Laboratory, the Veterinary Research
Department of the Kenya Agricultural Research Institute, the Ministry of Health and ICIPE.
Interlibrary loans increased in 1987, with ILRAD staff members borrowing 824 items from other
libraries in the network and the ILRAD library lending 645 items. The ILRAD -library also
donated 213 books and 181 journal issues to other libraries in the Nairobi area.
The ILRAD library offers current awareness services through weekly announcements of
accessions in the Internal Newsletter and through subscriptions to three monthly selective
dissemination of information services. These are provided as printouts by Biosciences
Information Services (BIOSIS), the International Information System for Agricultural Sciences
and Technology (AGRIS) of FAO and the abstracts service of the Commonwealth Agricultural
Bureaux International (CABI). Future plans include acquiring CABI Abstracts and other
databases in computerized form on CD-ROM as these become available.
The library carries out computer-based literature searches for ILRAD staff, using agents in
Europe. In 1987, ILRAD carried out 30 literature searches on a wide range of subjects. The
library also orders copies of scientific articles which are not available in Kenya as requested by
ILRAD staff members. In 1987, photocopies of 612 articles were purchased from the British
Library Document Supply Centre. All articles and reference lists acquired in response to
requests by individual staff members are retained in the library for other users.
Reprints of scientific articles by ILRAD staff members are supplied on request to researchers
and field workers, primarily in developing countries. The distribution of reprints was centralized
in the library in 1987 and 608 reprints were distributed free of charge.
Computerization of the library's catalogue and acquisition system was begun in 1986 and
completed in 1987; now the list of journals is being added to the data base. The next step will
be to acquire a system which will give library users access to the computerized catalogue. The
ILRAD library has supplied information and advice on library computerization to several other
organizations, including in 1987 the University of Nairobi, Kenyatta University and the Nairobi
office of the International Planned Parenthood Federation.
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 Tsetse laboratory
A great deal of the trypanosomiasis research conducted at ILRAD requires trypanosomes
which have developed in tsetse. Research on parasite development in the vector and
trypanosomiasis transmission is conducted in close collaboration with staff of the Tsetse
Laboratory.
ILRAD's Tsetse Laboratory maintained breeding colonies of seven tsetse species in 1987.
These were Glossina morsitans centralis originating from mainland Tanzania, G austeni from
Zanzibar, G palpalis palpalis from Nigeria, G p gambiensis from Burkina Faso, G fuscipes
fuscipes from the Central African Republic, G tachinoides from Tchad and G brevipalpis from
Kenya. These species represent the three taxonomic groups of tsetse—morsitans, palpalis
and fusca. Their breeding performance in 1987 is summarized in Figure 24.
Tsetse Species
Breeding
Females
(mean)
Daily Female
Mortality
(mean %)
Weekly Pupae
per Female
(mean)
Puparial 
Weight 
(mean mg)
Annual 
Number 
Puparia
G m centralis 10,510 0.37 0.62 33.63 340,036
G austeni 1,293 0.32 0.66 27.26 44,086
G p palpalis 1,303 0.84 0.56 32.06 37,890
G p gambiensis 1,414 0.62 0.71 29.34 51,312
G f fuscipes 1,342 0.37 0.53 36.99 36,719
G tachinoides 1,291 0.61 0.66 20.23 44,268
G brevipalpis 1,374 0.92 0.58 75.18 41,693
Figure 24. Performance of seven tsetse breeding colonies maintained at ILRAD in 1987.
Two new tsetse breeding colonies were established during the year from flies captured at two
different locations in Kenya. These are G pallidipes (morsitans group) from Shimba Hills and G
longipennis (fusca group) from Nguruman. By the end of 1987, the G pallidipes colony
consisted of 198 breeding females and had produced 1556 pupae with a mean puparial
weight of 41.04 mg. The G longipennis colony had 130 breeding females and had produced
557 pupae with a mean weight of 79.48 mg.
All breeding colonies are maintained at 25°C and fed 5 days a week on rabbits. G m centralis
and G austeni are kept at 70% relative humidity, and the other species at 80%.
These breeding colonies provided all the tsetse required for trypanosomiasis research at
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ILRAD in 1987, as well as tsetse used during two training courses conducted under the
African Trypanotolerant Livestock Network. Tsetse puparia and adult flies were also supplied
to colleagues at the University of Nairobi, the National Council for Scientific Research
(Zambia), the Federal Department of Pest Control (Nigeria), the Swiss Tropical Institute, the
Prince Leopold Institute of Tropical Medicine (Belgium), the University of Auckland (New
Zealand) and the University of Salford (UK).
 Tick laboratory
ILRAD's ECF research program requires a steady supply of the infective sporozoite forms of T
parva. The Tick Laboratory provides large numbers of sporozoites, ticks and tick tissues for a
variety of research projects.
Theileria sporozoites can only be obtained by continuous passage of the parasites between
the tick vectors and the mammalian hosts. In ILRAD's Tick Laboratory, ticks are infected with
Theileria parasites by feeding on infected cattle. They are then dissected and the sporozoites
are isolated from their salivary glands.
Colonies of infected and uninfected ixodid (hard) ticks are maintained by feeding on cattle and
rabbits. The most important species is Rhipicephalus appendiculatus, the principal vector of T
p parva and T p lawrencei in East Africa. Colonies of other tick species maintained at ILRAD
include Amblyomma variegatum and A gemma, vectors of Cowdria ruminantium (heartwater)
and of two relatively benign Theileria species—T mutans and T velifera; Boophilus
decoloratus and B microplus, which transmit Babesia spp and Anaplasma marginale; and
three other Rhipicephalus species, R evertsi evertsi, R pulchellus and R zambeziensis.
In 1987, facilities and procedures in ILRAD's Tick Laboratory were reviewed with the aim of
improving disease security. Future plans include some expansion and remodeling of the
facilities and the installation of a computerized system for storing and retrieving information on
the tick colonies.
 Large animal production
The large animal facilities at Kabete housed 590 cattle and 725 sheep and goats during 1987,
all allocated for research projects at ILRAD. Of these, 70% of the cattle were used for ECF
research, 25% for trypanosomiasis research and 5% for other projects, such as antigen
production. Most of the small ruminants were used for trypanosomiasis research.
ILRAD's ranch, Kapiti Plains Estate Ltd, supplied 217 Boran calves, 53 Bos taurus calves, 7
Boran steers, 6 Boran heifers and 13 Bos taurus heifers to ILRAD in 1987 and sold 617 cattle
to other users. Cattle production at Kapiti was adversely affected during the year by low
rainfall and by two outbreaks of foot and mouth disease, one on the ranch and one in the
neighbouring area. Quarantines were imposed on both occasions, interrupting the sale of
livestock from the ranch and leading to high stocking rates. Cattle at Kapiti are vaccinated 3
times a year against foot and mouth disease but the outbreak on the ranch in 1987 was
caused by a new, highly virulent strain which was not included in the vaccine. The disease
outbreak also interrupted embryo transfer work at Kapiti. Altogether, 967 calves were born on
the ranch during the year from a breeding herd of 1118 cows, resulting in a calving rate of
86%. Improvement of facilities at Kapiti included the construction of a workshop and staff
housing.
Both Boran and N'Dama calves are now produced at ILRAD by embryo transfer on a regular
basis. Over a 4-year period, methods have been tested and standardized for synchronizing
the ovulation of donor and recipient cows, stimulating superovulation in donors, assessing the
suitability of recipients and handling and splitting embryos before implantation. In both breeds,
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an average of just under three embryos is now obtained per embryo-producing donor during
each superovulation.
The objective of embryo transfer work, in Boran cattle is to produce animals of specific MHC
types, both as single calves and as twins. In 1987, 42 Boran calves were produced by embryo
transfer from selected, MHC-typed cows and bulls. This included 32 single calves matched for
one or both MHC haplotypes, plus 5 sets of identical twins produced by embryo-splitting.
Another 43 Boran calves of specified MHC type were produced during the year by natural
coatings.
ILRAD's five N'Dama heifers were superovulated four times between November 1986 and
November 1987. During this period, all the N'Dama were infected with trypanosomiasis. Unlike
susceptible cattle, these trypanotolerant N'Dama were capable of retaining reproductive
activity in spite of trypanosome infection. A total of 42 N'Dama embryos were recovered and
surgically transferred into Boran recipients, 22 pregnancies were established and 4 N'Dama
calves were born by the end of 1987. The goal is to increase the number of N'Dama available
for ILRAD's trypanosomiasis research program by producing as many N'Dama calves as
possible every year.
 Laboratory animal production
The Laboratory Animal Unit supports ILRAD's research and training activities with a regular
supply of mice, rats and rabbits. The unit also maintains small colonies of meadow voles
(Microtus montanus), Cotton rats (Sigmodon hispidus) and guinea pigs, which are
occasionally required for experimental work. All laboratory animals are housed and maintained
according to international animal welfare conventions.
ILRAD is generally self-sufficient in terms of mouse and rat production. Colonies of three
inbred mouse strains—BALB/c, C3H/He and C57/B16—are maintained. The C3H/He and
C57B16 mice are used primarily fo r studies on host resistance to trypanosomiasis. The
BALB/c mice and a colony of (BALB/c x Swiss) F1 mice are maintained for the production of
monoclonal antibodies. Random-bred Swiss mice are used increasingly for all other research
work because they are more productive and faster growing than the inbred strains. 
ILRAD scientists use rats primarily for the production of trypanosomes. All are random-bred,
originating from the Sprague Dawley strain. Rabbits are used mainly to produce antisera and
to support the tsetse and tick colonies. Expansion of rabbit production has been impeded by
outbreaks of Staphylococcus aureus. Although the number of rabbits weaned in 1987
increased by 32% over the 1986 level, ILRAD still relied on outside suppliers for about one-
third of the rabbits required during the year.
Figure 25 shows the total number of mice, rats and rabbits produced and used at ILRAD in
1987. The demand for mice decreased by 15% from the 1986 level, while the demand for rats
increased by 15% and the demand for rabbits increased by 13%. In addition to supplying
nearly all the laboratory animals required by ILRAD scientists, the breeding unit provided a
total of 2806 mice and 870 rats to other research organizations. In Kenya, these were the
Kenya Government's Veterinary Research Laboratory, the Kenya Trypanosomiasis Research
Institute (KETRI), the Kenya Medical Research Institute (KEMRI), the Institute for Primate
Research, four departments of the University of Nairobi and several secondary schools. Mice
were also donated to a heartwater research project in Zimbabwe and to the National
Veterinary Research Laboratory in Somalia.
Species and Strain
Number 
Weaned
Number Supplied 
to Scientists
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Mice
random-bred Swiss 30,362 19,762
inbred BALB/c 10,444 8,828
inbred C3H/He 5,271 3,524
inbred C57B1/6 2,986 1,674
BALB/c × Swiss F1 5,298 3,117
Rats 18,432 15,336
Rabbits 1,081 1,467
Figure 25. Rats, mice and rabbits produced and supplied to ILRAD scientists in 1987.
 Clinical and diagnostic services
The Diagnostic Laboratory carries out several types of routine analysis in support of ILRAD's
research program and animal production facilities. In 1987, a total of 37,519 samples were
received for analysis. These included 26,783 serological analyses, 3,001 bacteriological
analyses, 7,235 haematological analyses and 500 helminthological analyses. Serum samples
from experimental livestock were screened throughout the year for antibodies to seven
bloodstream parasites—Theileria parva, T mutans, Trypanosoma brucei, T congolenzse, T
vivax, Anaplasma marginale and Babesia bigemina.
In addition to services provided to ILRAD scientists, the Diagnostic Laboratory continued to
provide assistance to. other institutes and projects. In 1987, antigens, conjugates and
lymphocyte lysates were provided to the International Trypanotolerance Centre in The
Gambia, a German (FR) Gesellschaft fur technische Zusammenarbeit (GTZ) project in
Burundi, a Belgian Development Cooperation project in Zanzibar and the National Veterinary
Services in Australia. In addition, 30 serum samples were screened for antibodies to
bloodstream parasites for the Directorate of Animal Resources and Fisheries in Southern
Sudan.
Most screening for Theileria and Trpanosoma parasites was by IFA and ELISA. In 1987,
veterinarians from the National Health Laboratories in Uganda, the International Atomic Energy
Agency (IAEA) in Austria and the Belgian Development Cooperation agency visited ILRAD's
Diagnostic Laboratory to learn these techniques.
 Biostatistics and computing services
ILRAD's Biostatistics and Computing Services Unit, in conjunction with the University of
Strathclyde (UK), advises research staff on statistical problems and the installation and use of
microcomputers. Major projects in 1987 included statistical support for trypanosomiasis
experiments in N'Dama and Boran cattle, for ECF infection and treatment field trials at three
sites in Burundi and for a study on the frequency of cytolytic T cells in cattle immunized
against ECF. The Unit helps maintain databases on bovine MHC types and on all
trypanosome and tick-borne disease stabilates available at ILRAD. In 1987, the Unit helped
prepare a user's manual on ILRAD's automated MHC typing system.
Work continues on the expansion and improvement of ILRAD's telecommunications system.
Data communication with other centres in the CGIAR is fully functional through the CGNET
system and ILRAD is now also linked with research organizations and universities in many
countries through the BITNET international electronic mail service.
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Financial Statements
Rattansi Educational Trust Building, 
Koinange Street , 
P O Box 41968 
Nairobi, Kenya,
Telephone 21244, 
Telex: 22140 CHUNGA, 
Cables PRICEWATER, 
Telecopier 335937
Price Waterhouse
REPORT TO THE DIRECTORS OF THE INTERNATIONAL LABORATORY FOR RESEARCH
ON ANIMAL DISEASES (ILRAD)
We have reviewed the abridged financial statements set out in Figures 26 to 29 which contain
information extracted from the accounting records of ILRAD for the years ended 31 December
1986 and 1987.
We confirm that the information set out in the abridged financial statements is consistent with
that contained in the audited financial statements for the years ended 31 December 1986 and
1987, on which we expressed an unqualified opinion.
PRICE WATERHOUSE
Certified Public Accountants
15 April 1988
 1987 1986
Research
Parasitology—Trypanosomiasis 502 484
Biochemistry 675 640
Cell Biology 656 490
Immunobiology 653 484
Parasitology—Theileriosis 626 563
Pathology 649 605
Immunoparasitology 342 –
Tsetse Laboratory 345 314
Tick Laboratory 121 150
Electron Microscopy 142 131
Epidemiology and Socio-Economics 176 33
International Trypanotolerance
Centre—Gambia
204 -
Wildlife Project 220 -
Total Research 5311 3894
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Research Support
Office of Director of Research 470 550
Farm Animal Production 584 597
Laboratory Animal Production 170 209
Clinical and Diagnostic Services 57 88
Radioisotope and Central Core
Services
516 388
Total Research Support 1797 1832
 
Training and Conferences 1022 793
 
Library and Information Services 448 394
 
Administration
Board of Directors 108 86
Office of the Director General 444 373
Finance 334 342
Personnel 88 80
Purchasing 426 343
Total Administration 1400 1224
 
General Operations
Engineering 738 661
Transport 208 190
Services 285 237
Food and Housing 76 58
Stores 55 53
Total General Operations 1362 1199
 
Total Operations 11340 9336
Figure 26. Summary costs by program and activity (US$'000).
 1987 1986
Unrestricted Funds
United States Agency for International 2150 2525
Development (USAID)
World Bank (IBRD) 1250 1400
United Kingdom 930 794
Canadian International Development 760 730
Agency (CIDA)
Switzerland 644 474
Germany (Federal Republic) 630 510
Netherlands 350 280
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Japan 346 351
Sweden 340 290
Norway 285 250
Italy 232 170
Belgium 223 255
African Development Bank 190 190
France 133 90
Denmark 80 60
India 24 -
Australia ___- 230
Total Unrestricted Funds from Donors 8567 8599
Restricted Funds
United Nations Development Program
(UNDP)
828 766
Italy 570 500
Japan 215 150
Rockefeller Foundation 209 33
Belgium 195 95
Total Restricted Funds from Donors 2017 1544
Total Unrestricted/Restricted Funds from
Donors
10584 10143
Figure 27. Summary of core operating funds from donors (US$'000).
 1987 1986
SOURCES 
Core Operating Funds
Unrestricted
Unrestricted Funds from Donors 8567 8599
Earned Income Applied in Year 727 583
Total Unrestricted Operating Funds 9294 9182
Total Restricted Operating Funds 2017 1544
Total Unrestricted/Restricted Operating
Funds
11311 10726
Transfer to Capital Funds (962) (954)
Net Unrestricted/Restricted Operating
Funds
10349 9772
Capital Funds
Transferred from Core Operating Funds 962 954
Unexpended Balance from Previous Year 714 278
Balance of Working Funds 1123 823
Balance of Revolving Fund from Previous
Year
100 100
Total Capital Funds 2899 2155
Special Projects
Wildlife 220 156
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Trypanotolerance 204 296
Total Special Projects 424 452
TOTAL SOURCES 13672 12379
APPLICATIONS
Core Operations 11340 9788
Capital 962 954
Unexpended Balance
Unrestricted Core 55 714
Working Funds 1123 823
Revolving Fund 100 100
Capital Development Fund 92 -
TOTAL FUNDS 13672 12379
Figure 28. Summary of sources and application of funds (US$'000).
 1987 1986
ASSETS 
Fixed Assets
Land and Buildings 11279 10671
Research Equipment 5807 5415
Other Assets 1967 1869
Subsidiary Company
Investment 1786 1786
Longterm Loan 20 10
Total Fixed Assets 20859 19751
Revolving Fund 100 100
Capital Development Fund 92 –
Net Current Assets 1178 1537
TOTAL ASSETS
EMPLOYED 
22229 21388
FUND BALANCES 
Capital Fund 20859 19751
Working Capital 1123 823
Unrestricted Core Surplus 55 714
Revolving Fund 100 100
Capital Development Fund 92 -
TOTAL FUNDS 22229 21388
Figure 29. Balance sheet as at December 1987.

